government out-patients formulary list · government out-patients formulary list ... endometriosis...
TRANSCRIPT
Government Out-Patients
Formulary List
This formulary was compiled by the Directorate for Pharmaceutical Affairs
Ministry of Health, the Elderly and Community Care
March 2012
ii
Contents
How to use the formulary iii
The Schedule V Chronic Conditions iv
Dispensing vi
1. Gastro-Intestinal system 1
2. Cardiovascular system 5
3. Respiratory system 11
4. Central nervous system 14
5. Infections 23
6. Endocrine system 30
7. Obstetrics, gynaecology, and urinary-tract disorders 34
8. Malignant disease and immunosuppression 35
9. Nutrition and blood 39
10. Musculoskeletal and joint disease 43
11. Eye 45
12. Ear, nose, and oropharynx 47
13. Skin 49
14. Anaesthesia 53
15. Consumables 54
Appendixes and indices
Appendix 1 Borderline substances 55
Index 58
iii
How to use the formulary
Note:
� This formulary lists medicinal products that are available within the National
Health Scheme for Out-Patients use.
� Medicinal products listed can be issued via a Schedule V Card (Yellow
Card) once Schedule V entitlement is in place or to Pink Card holders if the
respective item is Pink Card Positive.
� Certain medicinal products are protocol regulated and will be supplied only
against the relevant approval in addition to the Schedule V Card.
� After hours, approval of protocol regulated drugs can be endorsed by the
Resident Specialist on duty, provided that it is then endorsed by its
respective consultant on the next day.
Abbreviations
A Acute
AG Antimicrobial Guidelines
ATC Anatomical Therapeutic Chemical Classification System
B Both Acute and Chronic
C Chronic
HDO Hospital Dispensing Only
HU Hospital Use
MDHP Mater Dei Hospital Pharmacy
MEU Medicines Entitlement Unit
MP Medicinal Protocol
N/A Not Applicable
TBDF To be dispensed from
U/L Unlicensed
Prescriber Criteria:
All Medical Practitioners, i.e. doctors working within the National Health
Services and private doctors, can change the dose of treatment for the
following conditions when an item is marked on the formulary as ‘Medical
Practitioners’ or ‘Consultant’. This includes also protocol-regulated items.
(Medicines that require permit/approval)
1. Hypertension
2. Diabetes Mellitus
3. Chronic Heart Failure
4. Asthma
5. Chronic Obstructive Pulmonary Disease
6. Treatment for hypercholesterolaemia under the respective Schedule V
conditions
7. Chronic Mood Disorders
8. Chronic Neurotic Disorders
iv
The Schedule V Chronic Conditions
The Fifth Schedule of the Social Security Act lists the diseases and conditions in
respect of which free medicines are provided irrespective of financial position.
These are as follows:
1. Malignant Diseases
2. Cardiovascular Diseases:
(a) Chronic Heart Failure
(b) Hypertension
(c) Ischaemic Heart Disease
(d) Cardiac Arrhythmias
(e) Peripheral Vascular Disease
(f) Cerebrovascular disease
(g) Genetic Dyslipidaemia
3. Respiratory Diseases:
(a) Chronic Respiratory Failure
(b) Cystic Fibrosis
(c) Chronic Obstructive Pulmonary Disease
(d) Chronic Asthma
4. Digestive system diseases:
(a) Gastro – Oesophageal Reflux Disease
(b) Gastric/Duodenal Ulcers
(c) Inflammatory Bowel Disease
(d) Coeliac Disease
(e) Diverticular Disease requiring Stoma Care
(f) Hirschprung’s Disease
(g) Imperforate Anus
(h) Small Intestinal Failure
5. Liver diseases:
(a) Chronic Liver Disease
6. Haematological Diseases:
(a) Inherited Bleeding Disorders
(b) Inherited Haemoglobinopathies
7. Nervous System Diseases:
(a) Epilepsy
(b) Parkinson’s disease
(c) Myasthenia Gravis
(d) Multiple Sclerosis
(e) Motor Neurone Disease
(f) Trigeminal Neuralgia
(g) Huntington’s Chorea
(h) Dementia
(i) Schizophrenia
(j) Psychosis
(k) Chronic Mood Disorders
(l) Chronic Neurotic Disorders
(m) Addiction Disorders
(n) Chronic Psychiatric Disorders starting in Childhood
(o) Chronic Eating Disorders
(p) Cerebral Palsy
(q) Narcolepsy
(r) Spinal Cord Pathologies
(s) Congenital indifference to pain
v
8. Renal diseases:
(a) Chronic Kidney Disease
9. Endocrine diseases:
(a) Diabetes Mellitus
(b) Addison’s Disease
(c) Precocious Puberty
(d) Hypoparathyroidism
(e) Hypopituitarism
(f) Hypogonadism
(g) Enzyme Disorders
(h) Endometriosis and Adenomyosis
(i) Pituitary Adenomas
10. Skin diseases:
(a) Psoriasis
(b) Chronic Immunobullous Disorders
(c) Congenital Ichthyosis
11. Infectious Diseases:
(a) HIV/AIDS and HIV Related Diseases
(b) Hepatitis B & C
(c) Tuberculosis
(d) Hospital Acquired Infections
(e) Leprosy
(f) Polio and Post-Polio Syndrome
(g) Chronic Osteomyelitis
12. Rheumatic Diseases:
(a) Rheumatoid Arthritis
(b) Paget’s Disease
(c) Lupus Erythematosus
(d) Systemic Sclerosis
(e) Dermatomyositis/Polymyositis
(f) Polyarteritis Nodosa
(g) Seronegative Arthritis
(h) Crystal Deposition Disease
(i) Polymyalgia Rheumatica
13. Metabolic Disorders:
a) Inborn errors of Metabolism
14. Eye diseases:
(a) Glaucoma
(b) Vascular Disease of the Retina
15. Immunodeficiency:
(a) Primary Immunodeficiency Disorder
(b) Secondary Immunodeficiency Disorder
16. Chromosome Disorders:
(a) Down Syndrome
(b) Turner Syndrome
(c) Prader-Willi Syndrome
vi
Dispensing When dispensing a formulary item, patient should present:
� Valid Schedule V card
� Prescription (white prescription [DH 46] and/or green prescription [DH 129] +
Control card [DH680i])
� Patient’s ID card and ID card of person who comes to collect the medicines
on the patient’s behalf
When dispensing a protocol regulated item, patient should present:
� Approval form
� Valid Schedule V card
� Prescription (white form [DH 46] and/or green form [DH 129] + Control card
[DH680i])
� Patient’s ID card and ID card of person who comes to collect the medicines
on the patient’s behalf
If an item is added to the Schedule V card in ink and endorsed by the
Consultant, the dispenser should dispense the newly added item once, and
instruct the patient to go to the Schedule V office for a new card to be issued.
If a Schedule V card is valid and there is no more space to log in dispensing
entries, patients should not be sent to the Schedule V office for a
Continuation Sheet/Card. Instead, a Continuation Sheet/Card is attached to
the Schedule V card, by the dispenser. The Continuation Sheet/Card is only
valid if attached to the valid issued Schedule V card. Dispensers are to make
sure that they have Continuation Sheets readily available.
If the Schedule V card is expired, the dispenser should dispense the items
once and instruct the patient to fix an appointment with the Consultant for the
renewal. The schedule V endorsed request can than be left at MDHP or sent to
the Schedule V office.
If a Schedule V Card Application with the relevant prescriptions is presented,
the dispenser should dispense the items once and instruct the patient to leave
the application at MDHP or send it to the Schedule V office.
Protocol Regulated Drugs
The requests for these drugs should be sent to the MEU (Medicines Entitlement
Unit) to be reviewed accordingly. The approval is given according to the
individual protocols and approved for a stated duration (in months or years)
depending on the specific item.
If the approval is expired, the dispenser should dispense the item once and
instruct the patient to fix an appointment with the Consultant for the renewal
requests endorsement. The endorsed request should be left at MDHP or sent
to the MEU.
If a request for a protocol regulated drug with the relevant prescription is
presented, the dispenser may dispense items for one month only if the item is
according to protocol.
vii
Genitourinary (GU) Clinic Entitlement
A legal notice (LN 188/2009) was issued containing a list of medicines that can
be dispensed by the consultant from the GU Clinic.
The legal notice entitled ‘Provision of Medicinal Products through the
Genitourinary Clinic within the Government Health Services Rules’ states that:
The medicinal products listed in the Schedule shall only be provided by the
consultant to patients attending or who have been referred to the clinic.
The consultant shall:
a. Provide the medicinal products referred to in the Schedule, directly to
patients attending the clinic, and he shall keep a record thereof;
b. Dispense only those amounts which are needed for the period specified
therein;
c. Immediately notify the Authority of any amendment needed in the
Schedule;
d. Inform the Authority of the address of the clinic and of any changes in such
an address;
e. Be responsible for all duties and obligations relating to the provision of
medicinal products to patients under the Act and any regulations or rules
made thereunder, and for standards and conditions issued by the Authority
from time to time in relation to dispensing;
f. Keep such amount of medicinal products as per internal arrangements with
the hospital pharmacy in order to ensure continuation of service at the
clinic;
g. Take all reasonable precautions to ensure appropriate storage and
dispensing of medicinal products;
h. Keep updated, written and agreed procedures with the hospital pharmacy
supplying the medicinal products.
List of medicinal products authorized for the purpose of these rules
1. Doxycycline 100mg bd for 7 days. (Occasionally for 14 days in epididymitis
and rarely for 28 days in LGV and Latent Syphilis)
2. Erythromycin 250mg - two tablets daily for 7 days
3. Metronidazole 200mg tablets - 2 tablets daily for 7 days
4. Ceftriaxone 250mg IM injections and 1% lignocaine injection for dilution to
be given as stat dose
5. Spectinomycin 2g IM stat
6. Benzathine Penicillin 1.2 million units IM injections and 1% lignocaine
injection for dilution to be given as stat dose of 2.4 million units.
7. Clotrimazole 100mg pessaries
8. Podophyllotoxin 0.15% cream
9. Podophyllotoxin 0.5% topical solution
10. Aciclovir 200mg to be given as 400mg tds for 7 days for acute episodes
11. Prednisolone 5mg to be given as 20mg tds for 3 days
12. Amoxicillin 250mg to be given as 500mg tds for 5 days
When dispensing one of the above mentioned drugs, a patient needs only to
present a prescription from GU consultant; there is no need of a Schedule II
card (Pink Card) or a Schedule V card. This applies for the 12 drugs mentioned
in the Legal Notice only.
viii
Other Information
Medicines Entitlement Unit
Address: St. Luke’s Hospital, Guardamangia (ex Out-Patients Pharmacy)
Tel: 2123 2424 (Available from Monday to Friday from 8.30am to 12.00pm)
Opening Hours:
Monday, Wednesday, Friday 7.30am – 2.30pm
V1.3 March 2012
1. Gastro-intestinal System 1
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
1. Gastro-intestinal system 1.1 Dyspepsia and gastro-oesophageal reflux disease
1.1.1 Antacids and simeticone
A02AC01 Calcium Carbonate Tablets 500mg Consultants A02AX Magnesium Hydroxide +
Aluminium Hydroxide + Simeticone Oral Liquid Medical Practitioners A
A02AA04 Magnesium Hydroxide Mixture Oral Liquid Medical Practitioners A
1.1.2 Compound alginates and proprietary indigestion preparations A02AX Antacid Compound Preparation Tablets Medical Practitioners A
1.2 Antispasmodics and other drugs altering gut motility A03AB01 Atropine Sulphate Tablets 0.6mg Consultant Neurologists, Consultant Geriatricians, Consultant
Paediatricians MP 13
A03BB01 Hyoscine Butylbromide Injections 20mg Consultant Palliative Care HDO A03BB01 Hyoscine Butylbromide Tablets 10mg Medical Practitioners A A03AA04 Mebeverine Hydrochloride Tablets 135mg Medical Practitioners C A03AB05 Propantheline Bromide Tablets 15mg Medical Practitioners A
1.3 Antisecretory drugs and mucosal protectants
1.3.1 H2-Receptor antagonists
A02BA03 Ranitidine Syrup Consultant Geriatricians, Consultant Oncologists, Consultant Paediatricians, Consultant Gastroenterologists, Consultant Palliative Care
MP 172
A02BA02 Ranitidine Tablets 150mg Medical Practitioners B
1.3.2 Chelates and complexes
A07BB Bismuth Chelate Tablets 120mg Consultant Gastroenterologists, Consultant Surgeons A02BX02 Sucralfate Oral Liquid 1g/5mL Consultant Gastroenterologists, Consultant Paediatricians,
Consultant Geriatricians MP 184
A02BX02 Sucralfate Tablets 1g Consultants C
V1.3 March 2012
1. Gastro-intestinal System 2
1.3.3 Prostaglandin analogues
A02BB01 Misoprostol Tablets 200mcg Consultant Rheumatologists, Consultant Gastroenterologists, Consultant Obstetrics & Gynaecology, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 132
1.3.4 Proton pump inhibitors
A02BC01 Omeprazole Capsules 20mg Medical Practitioners B
1.4 Acute diarrhoea
1.4.1 Antimotility drugs
N02AA Codeine Phosphate Tablets 30mg Hospital Doctors A07DA032 Loperamide Capsules 2mg Medical Practitioners A
1.5 Chronic bowel disorders
1.5.1 Aminosalicylates
A07EC02 Mesalazine Enema 1g Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons
A07EC02 Mesalazine Suppositories 500mg
Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons
A07EC02 Mesalazine Tablets 400mg Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons
C
A07EC02 Mesalazine (Pentasa ®) Slow Release Tablets 500mg
Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons
MP 125
A07EC02 Sulfasalazine Oral Liquid 250mg/mL
Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons
MP 186
A07EC01 Sulfasalazine Suppositories 500mg
Consultant Gastroenterologists MP 185
A07EC01 Sulfasalazine Tablets 500mg Consultant Gastroenterologists, Consultant Paediatricians, Consultant Surgeons, Consultant Rheumatologists
1.5.2 Corticosteroids
A07EA06 Budesonide Controlled Release Capsules 3mg
Consultant Gastroenterologists, Consultant Surgeons MP 23
A07EA06 Budesonide Enema 2mg/100mL Consultant Gastroenterologists, Consultant Surgeons MP 24 A07EA02 Hydrocortisone Foam Enema 10% Consultant Gastroenterologists, Consultant Surgeons, Consultant
Paediatricians C
A07EA01 Prednisolone Retention Enema 20mg/100mL
Consultant Gastroenterologists, Consultant Surgeons, Consultant Paediatricians, Consultant Oncologists, Consultant Palliative Care
V1.3 March 2012
1. Gastro-intestinal System 3
1.5.3 Drugs affecting the immune response
L04AX01 Azathioprine Tablets 50mg Hospital Doctors L04AD01 Ciclosporin (Cyclosporin) Capsules 100mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Capsules 25mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Oral Solution
100mg/mL Consultant Nephrologists, Consultant Dermatologists, Consultant Rheumatologists, Consultant Paediatricians, Consultant Haematologists, Consultant Cardiac Surgeons
MP 47
L01BB02 Mercaptopurine Tablets 50mg Consultants L04AX03 Methotrexate Tablets 2.5mg Consultants
1.6 Laxatives
1.6.1 Bulk-forming laxatives
A06AC01 Ispaghula Husk Powder Medical Practitioners B A06AC06 Methylcellulose Tablets 500mg Hospital Doctors
1.6.2 Stimulant laxatives
A06AB02 Bisacodyl Suppositories 10mg Medical Practitioners A A06AB02 Bisacodyl Tablets 5mg Medical Practitioners A A06AB53 Co-Danthramer Suspension 75/1000
in 5mL Consultant Oncologists, Consultant Palliative Care MP 43
A06AX01 Glycerol Adult Suppositories 4g
Medical Practitioners A
A06AX01 Glycerol Infant Suppositories 1g
Medical Practitioners A
A06AB06 Senna Tablets 7.5mg Medical Practitioners A
1.6.3 Osmotic laxatives
A06AD11 Lactulose Syrup 3.35g/5mL Consultants MP 109 A02AA04 Magnesium Hydroxide Mixture Oral Liquid Medical Practitioners A A06AG Phosphate Enema Medical Practitioners A
1.7 Drugs affecting intestinal secretions
1.7.1 Drugs affecting biliary composition and flow
A05AA02 Ursodeoxycholic Acid Capsules 150mg Consultant Gastroenterologists A05AA02 Ursodeoxycholic Acid Capsules 250mg Consultant Gastroenterologists
1.7.2 Bile acid sequestrants
C10AC01 Colestyramine Powder Medical Practitioners C
V1.3 March 2012
1. Gastro-intestinal System 4
1.7.3 Pancreatin
A09AA02 Pancreatin Capsules (Creon 10,000U)
Consultants
A09AA02 Pancreatin Tablets Medical Practitioners C A09AA02 Pancreatin Tablets High Dose Medical Practitioners C
V1.3 March 2012
2. Cardiovascular System 5
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
2. Cardiovascular system 2.1 Positive inotropic drugs
2.1.1 Cardiac glycosides
C01AA05 Digoxin Elixir 0.05mg/mL Consultants C C01AA05 Digoxin Tablets 0.0625mg Medical Practitioners C C01AA05 Digoxin Tablets 0.25mg Medical Practitioners C
2.2 Diuretics
2.2.1 Thiazides and related diuretics
C03AA01 Bendroflumethiazide (Bendrofluazide)
Tablets 2.5mg Medical Practitioners C
C03AA01 Bendroflumethiazide (Bendrofluazide)
Tablets 5mg Medical Practitioners C
C03BA08 Metolazone Tartrate Tablets 5mg Consultant Physicians MP 128
2.2.2 Loop diuretics
C03CA02 Bumetanide Tablets 1mg Medical Practitioners C C03CA02 Bumetanide Tablets 5mg Medical Practitioners C C03CA01 Furosemide Syrup 1mg/mL Consultants C03CA01 Furosemide Tablets 40mg Medical Practitioners C
2.2.3 Potassium-sparing diuretics and aldosterone antagonists
C03DB01 Amiloride Hydrochloride Tablets 5mg Consultants C03DA01 Spironolactone Tablets 25mg Medical Practitioners C C03DA01 Spironolactone Tablets 100mg Consultants
2.2.4 Potassium-sparing diuretics with other diuretics
C03EA01 Amiloride + Hydrochlorothiazide Tablets 5mg + 50mg
Medical Practitioners C
C03EB01 Co-amilofruse (Amiloride + Furosemide [Frusemide])
Tablets 5mg + 40mg
Consultant Cardiologists, Consultant Cardiac Surgeons
MP 82
V1.3 March 2012
2. Cardiovascular System 6
2.3 Anti-arrhythmic drugs C01BD01 Amiodarone HCl Tablets 200mg Consultants C01BA03 Disopyramide Tablets 100mg Consultants C C01BC04 Flecainide Tablets 100mg Consultants C01BB02 Mexiletine HCl Tablets 200mg Consultant Cardiologists C01BC03 Propafenone Tablets 150mg Consultant Physicians, Consultant Cardiologists MP 169 C01BA01 Quinidine Bisulphate Modified Release
Tablets 250mg Consultants
2.4 Beta-adrenoceptor blocking drugs C07AB03 Atenolol Tablets 25mg Medical Practitioners C C07AB03 Atenolol Tablets 100mg Medical Practitioners C C07AG02 Carvedilol Tablets 6.25mg Consultants C07AG02 Carvedilol Tablets 25mg Consultants C07AG01 Labetalol Hydrochloride Tablets 100mg Hospital Doctors C C07AG01 Labetalol Hydrochloride Tablets 200mg Hospital Doctors C C07AB02 Metoprolol Tartrate Tablets 50mg Consultants C07AB02 Metoprolol Tartrate Tablets 100mg Consultants C07AA05 Propranolol Hydrochloride Oral Solution
1mg/mL Consultant Paediatricians
C07AA05 Propranolol Hydrochloride Tablets 10mg Medical Practitioners C C07AA05 Propranolol Hydrochloride Tablets 40mg Medical Practitioners C C07AA07 Sotalol Tablets 80mg Consultants
2.5 Hypertension and heart failure
2.5.1 Vasodilator antihypertensive drugs
C02DB02 Hydralazine Tablets 25mg Medical Practitioners C C02DC01 Minoxidil Tablets 10mg Consultant Physicians, Consultant Cardiologists MP 130
2.5.2 Centrally acting antihypertensive drugs
C02AC01 Clonidine Hydrochloride Tablets 100mcg Consultants C C02AB Methyldopa Tablets 250mg Medical Practitioners C
2.5.3 Alpha-adrenoceptor blocking drugs
C02CA04 Doxazosin Tablets 1mg Consultants C02CA04 Doxazosin Tablets 2mg Consultants C
(Consultant Urologist)
C02CA04 Doxazosin Tablets 4mg Consultants
V1.3 March 2012
2. Cardiovascular System 7
C04AX02 Phenoxybenzamine Capsules 10mg Consultant Intensivists MP 238 C02CA01 Prazosin Hydrochloride Tablets 1mg Consultant Physicians, Consultant Cardiologists, Consultant
Cardiac Surgeons MP 166
C02CA01 Prazosin Hydrochloride Tablets 500mcg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 166
2.5.4 Drugs affecting the renin-angiotensin system
2.5.4.1 Angiotensin-converting enzyme inhibitors
C09AA01 Captopril Tablets 12.5mg Medical Practitioners C C09AA01 Captopril Tablets 25mg Medical Practitioners C C09AA01 Captopril Tablets 50mg Medical Practitioners C C09AA02 Enalapril Tablets 5mg Medical Practitioners C C09AA02 Enalapril Tablets 20mg Medical Practitioners C C09AA03 Lisinopril Tablets 5mg Consultants C09AA03 Lisinopril Tablets 10mg Consultants C09AA04 Perindopril Tablets 4mg Consultants
2.5.4.2 Angiotensin-II-receptor antagonists
C09CA01 Losartan Potassium Tablets 50mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 9
C09CA03 Valsartan Tablets 80mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 9
C09CA03 Valsartan Tablets 160mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 9
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6.1 Nitrates
C01DA02 Glyceryl Trinitrate Sublingual tablets 500mcg
Medical Practitioners C
C01DA02 Glyceryl Trinitrate Transdermal Patches 5mg/24hrs
Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
C01DA02 Glyceryl Trinitrate Transdermal Patches 10mg/24hrs
Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
C01DA08 Isosorbide Dinitrate Tablets 10mg Medical Practitioners C C01DA14 Isosorbide Mononitrate Tablets 20mg Consultant Physicians, Consultant Cardiologists, Consultant
Cardiac Surgeons, Consultant Gastroenterologists
V1.3 March 2012
2. Cardiovascular System 8
C01DA14 Isosorbide Mononitrate
Tablets SR 60mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
2.6.2 Calcium-channel blockers
C08CA01 Amlodipine Tablets 5mg Consultants C08CA01 Amlodipine Tablets 10mg Consultants C08DB01 Diltiazem Tablets 60mg Consultants C08CA05 Nifedipine Modified Release
Tablets 10mg Consultants
C08CA05 Nifedipine Slow Release Capsule/Tablets 20mg
Consultants
C08CA05 Nifedipine Tablets/Capsules 10mg
Consultants
C08CA06 Nimodipine Tablets 30mg Consultant Neurologists MP 146 C08DA01 Verapamil Slow Release
Tablets 240mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
MP 196
C08DA01 Verapamil Tablets 40mg Medical Practitioners C
2.6.3 Other antianginal drugs
C01DX16 Nicorandil Tablets 10mg Consultant Physicians, Consultant Cardiologists MP 144
2.6.4 Peripheral vasodilators and related drugs
C04AD03 Pentoxifylline (Oxypentifylline) Tablets 400mg Consultant Cardiologists, Consultant Cardiac Surgeons, Consultant Vascular Surgeons, Consultant Rheumatologists
2.6.5 3-KAT inhibitors
C01EB15 Trimetazidine Hydrochloride Tablets 20mg Consultant Physicians, Consultant Cardiologists, Consultant Cardiac Surgeons
2.7 Anticoagulants and protamine
2.7.1 Parenteral anticoagulants
B01AB01 Heparin Calcium Prefilled Syringes 2500 IU/mL in 0.2mL
Consultants B
B01AB01 Heparin Sodium in Sodium Chloride
Injection 10Units/mL in 5mL
Hospital Doctors TBDF MDHP only (TPN patients)
B01AB05 Enoxaparin Sodium Vials for injection single dose 20mg
Consultants MP 204
V1.3 March 2012
2. Cardiovascular System 9
B01AB05 Enoxaparin Sodium Vials for injection single dose 40mg
Consultants MP 204
B01AB05 Enoxaparin Sodium Vials for injection single dose 60mg
Consultants MP 204
B01AB05 Enoxaparin Sodium Vials for injection single dose 80mg
Consultants MP 204
B01AB05 Enoxaparin Sodium Vials for injection single dose 100mg
Consultants MP 204
2.7.2 Oral anticoagulants
B01AA02 Phenindione Tablets 50mg Consultants B01AA03 Warfarin Tablets 1mg Hospital Doctors C B01AA03 Warfarin Tablets 3mg Hospital Doctors C B01AA03 Warfarin Tablets 5mg Hospital Doctors C
2.8 Antiplatelet drugs B01AC06 Aspirin Tablets 75mg Medical Practitioners C B01AC04 Clopidogrel Tablets 75mg Consultant Physicians MP 276 B01AC07 Dipyridamole Tablets 25mg Medical Practitioners C B01AC07 Dipyridamole Tablets 100mg Medical Practitioners C
2.9 Antifibrinolytic drugs and heamostatics B02BD02 Anti-Haemophilic Factor VIII Infusion 500IU Consultant Haematologists, Consultant Paediatricians, Consultant
Infectious Diseases Physician TBDF MDHP only
B02BD02 Anti-Haemophilic Factor VIII Infusion 1000IU Consultant Haematologists, Consultant Paediatricians, Consultant Infectious Diseases Physician
TBDF MDHP only
B02BD06 Anti-Heamophilic Factor VIII Intermediate
Injection IV 500IU Consultant Haematologists, Consultant Paediatricians, Consultant Infectious Diseases Physicians
TBDF MDHP only
B02BD03 Anti-Haemophilic Factor VIII inhibitor bypassing activity
Injection IV 500IU Consultant Haematologists, Consultant Paediatricians, Consultant Infectious Diseases Physicians
TBDF MDHP only
B02BD04 Anti-Haemophilic Factor IX Infusion 500IU Consultant Haematologists, Consultant Paediatricians, Consultant Infectious Diseases Physicians
TBDF MDHP only
B02BD08 Eptacog Alfa (Recombinant Factor VIIa) (stand-by)
Vials Consultant Anaesthetists, Consultant Haematologists TBDF MDHP only
B02BB01 Fibrinogen Concentrate (stand-by) Vials Consultants Haematologists TBDF MDHP only MP 212
B02BD07 Factor XIII Concentrate Vials Consultant Haematologists MP 211 B02AA02 Tranexamic Acid Tablets 500mg Consultants
V1.3 March 2012
2. Cardiovascular System 10
2.10 Lipid-regulating drugs C10AD06 Acipimox Capsules 250mg Consultant Physicians MP 1 C10AA05 Atorvastatin Tablets 10mg Consultants MP 12
C10AA05 Atorvastatin Tablets 20mg Consultants MP 12
C10AA05 Atorvastatin Tablets 40mg Consultants MP 12
C10AA05 Atorvastatin Tablets 80mg Consultants MP 12
C10AB02 Bezafibrate Tablets 400mg Medical Practitioners C10AC02 Colestipol Powder Medical Practitioners C10AC01 Colestyramine Powder Medical Practitioners C10AB05 Fenofibrate Non-micronised
300mg capsules, or Micronised 200mg capsules, or Tablets 145mg
Medical Practitioners
C10AB05 Fenofibrate Non-micronised 100mg capsules or Micronised 67mg Capsules
Medical Practitioners
C10AA04 Fluvastatin Capsules 40mg Consultants MP 71 C10AA04 Fluvastatin Prolonged Release
Tablets 80mg Consultants MP 71
C10AA01 Simvastatin Tablets 10mg Medical Practitioners C10AA01 Simvastatin Tablets 20mg Medical Practitioners
V1.3 March 2012
3. Respiratory System 11
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
3. Respiratory system 3.1 Bronchodilators
H02AB06 Prednisolone Soluble Tablets 5mg Consultant Paediatricians H02AB06 Prednisolone Tablets 1mg Medical Practitioners B H02AB06 Prednisolone Tablets 5mg Medical Practitioners, GU Clinic Consultant B H02AB06 Prednisolone Tablets enteric-
coated 5mg Medical Practitioners B
H02AB06 Prednisone Acetate Suppositories 30mg Consultant Paediatricians MP 167
3.1.1 Adrenoceptor agonists
3.1.1.1 Selective beta2 agonists
R03AC12 Salmeterol Inhaler Consultant Respiratory Physicians, Consultant Paediatricians MP 270 R03AC12/ R03AC13
Long Acting Beta2-Agonist for patients over 12 years inhaler
Inhaler Consultant Respiratory Physicians, Consultant Paediatricians MP 271
R03AC02 Salbutamol Inhaler 100mcg/puff Medical Practitioners B R03AC02 Salbutamol Respiratory Solution
5mg/mL Medical Practitioners C
R03AC02 Salbutamol Syrup 2mg/5mL Medical Practitioners B R03AC02 Salbutamol Tablets 4mg Medical Practitioners B R03AC03 Terbutaline Dry Powder Inhaler
500mcg Consultant Respiratory Physicians, Consultant Paediatricians MP 206
3.1.2 Antimuscarinic bronchodilators
R03BB01 Ipratropium Inhaler 20mcg/dose Consultants R03BB01 Ipratropium Nebuliser Solution
250mcg/mL Consultants
3.1.3 Theophylline
R03DA04 Theophylline Tablets 250mg Hospital Doctors
3.2 Corticosteroids R03BA01 Beclometasone Dipropionate Inhaler 50mcg Medical Practitioners B R03BA01 Beclometasone Dipropionate Inhaler 250mcg Consultants
V1.3 March 2012
3. Respiratory System 12
R03BA02 Budesonide Breath-Actuated Metered Dose Powder Inhaler 100mcg/Dose
Consultant Respiratory Physicians, Consultant Paediatricians MP 27
R03BA02 Budesonide Inhaler 50mcg/Dose Consultants MP 25 R03BA02 Budesonide Inhaler
200mcg/Dose Consultants MP 26
R03BA02 Budesonide Nebuliser Solution Ampoules 0.25mg/mL
Consultant Respiratory Physicians, Consultant Paediatricians, Consultant Oncologists
MP 28
R03BA02 Budesonide Nebuliser Solution Ampoules 0.5mg/mL
Consultant Respiratory Physicians, Consultant Paediatricians, Consultant Oncologists
MP 28
R03BA05 Fluticasone Inhaler 50mcg Consultant Respiratory Physicians, Consultant Paediatricians MP 77 R03BA05 Fluticasone Inhaler 250mcg Consultant Respiratory Physicians, Consultant Paediatricians MP 78
3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
3.3.1 Leukotriene Receptor Antagonists
R03DC03 Montelukast Chewable Tablets 5mg
Consultant Respiratory Physicians, Consultant Paediatricians MP 295
R03DC03 Montelukast Tablets 10mg Consultant Respiratory Physicians, Consultant Paediatricians MP 295
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4.1 Antihistamines
R06AD01 Alimemazine (Trimeprazine Tartrate)
Syrup 30mg/5mL Hospital Doctors
R06AX02 Cyproheptadine Hydrochloride Tablets 4mg Consultants A N05BB01 Hydroxyzine Hydrochloride Tablets 25mg Medical Practitioners B N06AD02 Promethazine Hydrochloride Syrup 5mg/5mL Medical Practitioners A N06AD02 Promethazine Hydrochloride Tablets 10mg Medical Practitioners B N06AD02 Promethazine Hydrochloride Tablets 25mg Medical Practitioners B
3.4.2 Allergen Immunotherapy
R03DX05 Omalizumab Injections 150mg Consultant Respiratory Physicians, Consultant Paediatricians MP 294
3.5 Oxygen V03AN01 Medical Oxygen 1.5m³ Gas Medical Practitioners
V1.3 March 2012
3. Respiratory System 13
3.6 Mucolytics R05CB02 Bromhexine Syrup 8mg/10mL Medical Practitioners A R05CB02 Bromhexine Tablets 8mg Medical Practitioners A
3.7 Aromatic inhalations R01AX10 Benzoin Tincture Tincture 50mL Medical Practitioners A
3.8 Cough preparations
3.8.1 Cough suppressants
R05DA04 Codeine Phosphate Suspension 15mg/5mL
Medical Practitioners B
3.8.2 Expectorant and demulcent cough preparations
R06AA52 Diphenhydramine Citrate + Menthol
Syrup 125mL Medical Practitioners A
V1.3 March 2012
4. Central Nervous System 14
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
4. Central nervous system 4.1 Hypnotics and anxiolytics
4.1.1 Hypnotics
N05BA01 Diazepam Syrup 2mg/5mL Medical Practitioners B N05BA01 Diazepam Tablets 2mg Medical Practitioners B N05BA01 Diazepam Tablets 5mg Medical Practitioners B N05CD02 Nitrazepam Tablets 5mg Medical Practitioners B N06AD02 Promethazine Hydrochloride Syrup 5mg/5mL Medical Practitioners A N06AD02 Promethazine Hydrochloride Tablets 10mg Medical Practitioners B N06AD02 Promethazine Hydrochloride Tablets 25mg Medical Practitioners B N05CD07 Temazepam Tablets 10mg Consultants B
4.1.2 Anxiolytics
N05BA08 Bromazepam Tablets 1.5mg Medical Practitioners B N05BA08 Bromazepam Tablets 3mg Medical Practitioners B N05BA08 Bromazepam Tablets 6mg Medical Practitioners B N05BE01 Buspirone Hydrochloride Tablets 10mg Consultants N05BA01 Diazepam Rectal Tubes
5mg/2.5mL Medical Practitioners B
N05BA01 Diazepam Rectal Tubes 10mg/2.5mL
Medical Practitioners B
N05BA01 Diazepam Syrup 2mg/5mL Medical Practitioners B N05BA01 Diazepam Tablets 2mg Medical Practitioners B N05BA01 Diazepam Tablets 5mg Medical Practitioners B N05BA06 Lorazepam Tablets 1mg Medical Practitioners B N05BA06 Lorazepam Tablets 2mg Medical Practitioners B
4.2 Drugs used in psychoses and related disorders
4.2.1 Antipsychotic drugs
N05AA01 Chlorpromazine Hydrochloride Tablets 25mg Medical Practitioners C N05AA01 Chlorpromazine Hydrochloride Tablets 100mg Medical Practitioners C
V1.3 March 2012
4. Central Nervous System 15
N05AH02 Clozapine Tablets 25mg Consultant Psychiatrists MP 42 N05AH02 Clozapine Tablets 100mg Consultant Psychiatrists MP 42 N05AF01 Flupentixol Dihydrochloride Tablets 0.5mg Consultant Psychiatrists N05AD01 Haloperidol Capsules 0.5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant
Oncologists, Consultant Geriatricians C
N05AD01 Haloperidol Injections 5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists
N05AD01 Haloperidol Oral Solution 2mg/mL
Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AD01 Haloperidol Tablets 1.5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AD01 Haloperidol Tablets 5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AA02 Levomepromazine Tablets 25mg Consultant Paediatricians, Consultant Oncologists, Consultant Palliative Care
MP 287
N05AH03 Olanzapine Coated Tablets 10mg
Consultant Psychiatrists
N05AH03 Olanzapine Coated Tablets 5mg Consultant Psychiatrists N05AG02 Pimozide Tablets 4mg Consultant Psychiatrists N05AB04 Prochlorperazine Tablets 5mg Medical Practitioners A N05AH04 Quetiapine Tablets 25mg Consultant Psychiatrists N05AH04 Quetiapine Tablets 100mg Consultant Psychiatrists N05AH04 Quetiapine Tablets 200mg Consultant Psychiatrists N05AX08 Risperidone Syrup 1mg/mL Consultant Psychiatrists MP 175 N05AX08 Risperidone Tablets 1mg Consultant Psychiatrists C N05AX08 Risperidone Tablets 2mg Consultant Psychiatrists C N05AL01 Sulpiride Capsules 50mg Consultant Psychiatrists N05AL01 Sulpiride Suspension
5mg/5mL Consultant Psychiatrists
N05AL01 Sulpiride Tablets 200mg Consultant Psychiatrists N05AB06 Trifluoperazine Syrup 1mg/5mL Hospital Doctors N05AB06 Trifluoperazine Tablets 1mg Medical Practitioners C N05AB06 Trifluoperazine Tablets 5mg Medical Practitioners C N05AF05 Zuclopenthixol Acetate Oily injection 50mg Consultant Psychiatrists N05AF05 Zuclopenthixol Acetate Oily injection 100mg Consultant Psychiatrists N05AF05 Zuclopenthixol Dihydrochloride Tablets 2mg Consultant Psychiatrists N05AF05 Zuclopenthixol Dihydrochloride Tablets 10mg Consultant Psychiatrists
V1.3 March 2012
4. Central Nervous System 16
N05AF05 Zuclopenthixol Dihydrochloride Tablets 25mg Consultant Psychiatrists
4.2.2 Antipsychotic depo injections
N05AF01 Flupentixol Decanoate Injection 20mg/mL Consultant Psychiatrists N05AF01 Flupentixol Decanoate Injection 100mg/mL Consultant Psychiatrists N05AB02 Fluphenazine Decanoate Injection 25mg Consultant Psychiatrists N05AB02 Fluphenazine Decanoate Injection 100mg Consultant Psychiatrists N05AD01 Haloperidol Decanoate Injection 50mg Consultant Psychiatrists N05AD01 Haloperidol Decanoate Injection 100mg Consultant Psychiatrists N05AX08 Risperidone Depot Injection
25mg Consultant Psychiatrists MP 291
N05AX08 Risperidone Depot Injection 37.5mg
Consultant Psychiatrists MP 291
N05AX08 Risperidone Depot Injection 50mg
Consultant Psychiatrists MP 291
N05AF05 Zuclopenthixol Decanoate Injection 200mg Consultant Psychiatrists
4.2.3 Antimanic drugs
N05AN01 Lithium Carbonate Tablets 400mg Medical Practitioners C N05AN01 Lithium Citrate Syrup 520mg/5mL Consultant Psychiatrists MP 120
4.3 Antidepressant drugs
4.3.1 Tricyclic and related antidepressant drugs
N06AA09 Amitriptyline (U/L) Syrup 10mg/5mL Consultant Psychiatrists, Consultant Paediatricians, Consultant Oncologists, Consultant Palliative Care
N06AA09 Amitriptyline Tablets 10mg Medical Practitioners B N06AA09 Amitriptyline Tablets 25mg Medical Practitioners B N06AA04 Clomipramine Hydrochloride Tablets 10mg Medical Practitioners C N06AA05 Clomipramine Hydrochloride Tablets 25mg Medical Practitioners C N06AA02 Imipramine Hydrochloride Tablets 10mg Medical Practitioners C N06AA02 Imipramine Hydrochloride Tablets 25mg Medical Practitioners C N06AA21 Maprotiline Hydrochloride Tablets 25mg Hospital Doctors N06AX03 Mianserin Hydrochloride Tablets 10mg Medical Practitioners C N06AX03 Mianserin Hydrochloride Tablets 30mg Medical Practitioners C N06AA09 Nortriptyline Tablets 10mg Medical Practitioners C N06AA09 Nortriptyline Tablets 25mg Medical Practitioners C N06AA06 Trimipramine Tablets 10mg Medical Practitioners C N06AA06 Trimipramine Tablets 25mg Medical Practitioners C N06AA06 Trimipramine Tablets 50mg Medical Practitioners C
V1.3 March 2012
4. Central Nervous System 17
4.3.2 Monoamine-oxidase inhibitors
N06AG02 Moclobemide Tablets 150mg Consultant Psychiatrists MP 134
4.3.3 Selective serotonin re-uptake inhibitors
N06AB03 Fluoxetine Tablets 20mg Consultant Psychiatrists C N06AB08 Fluvoxamine Maleate Tablets 100mg Consultant Psychiatrists N06AB05 Paroxetine Tablets 20mg Consultant Psychiatrists, Consultant Palliative Care C
4.3.4 Other antidepressant drugs
N05AF01 Flupentixol Dihydrochloride Tablets 0.5mg Consultant Psychiatrists N06AX16 Venlafaxine Modified Release
Capsules 75mg Consultant Psychiatrists
N06AX16 Venlafaxine Modified Release Capsules 150mg
Consultant Psychiatrists
4.4 CNS stimulants and drugs used in attention deficit hyperactivity disorder N06BA02 Dexamphetamine Sulphate Tablets 5mg Consultants N06BA04 Methylphenidate Hydrochloride Tablets 10mg Consultant Psychiatrists C
4.5 Drugs used in nausea and vertigo A04AD12 Aprepitant Capsules 80mg Consultant Oncologists, Consultant Palliative Care MP 269 A04AD12 Aprepitant Capsules 125mg Consultant Oncologists, Consultant Palliative Care MP 269 R06AE03 Cyclizine Ampoules 50mg/mL Consultant Anaesthetists, Consultant Obstetricians and
Gynaecologists, Consultant Oncologists, Consultant Palliative Care MP 267
R06AE03 Cyclizine Tablets 50mg Hospital Doctors A R06AA02 Dimenhydrinate Tablets 50mg Medical Practitioners A A03FA03 Domperidone Suppositories 30mg Consultants A A03FA03 Domperidone Suspension 1mg/mL Consultants MP 57 C A03FA03 Domperidone Tablets 10mg Consultants MP 56 C A03FA01 Metoclopramide Ampoules 10mg/mL Hospital Doctors, Consultant Oncologists and Consultant Palliative
Care for outpatients use HU/HDO
A03FA01 Metoclopramide Tablets 10mg Medical Practitioners A A04AA01 Ondansetron Syrup 4mg/5mL Consultant Paediatricians, Paediatric Surgeons, Consultant
Palliative Care, Consultant Oncologists MP 153
A04AA01 Ondansetron Tablets 4mg Consultants MP 154 A04AA01 Ondansetron Tablets 8mg Consultants MP 154 N05AB04 Prochlorperazine Tablets 5mg Medical Practitioners A
V1.3 March 2012
4. Central Nervous System 18
4.6 Analgesics
4.6.1 Non-opioid analgesics
N02BA01 Aspirin Effervescent Tablets 300mg
Medical Practitioners B
N02BA01 Aspirin Tablets 300mg Medical Practitioners B N02BE01 Paracetamol Suppositories
100mg or 125mg Medical Practitioners A
N02BE01 Paracetamol Suppositories 250mg
Medical Practitioners A
N02BE01 Paracetamol Suppositories 500mg
Medical Practitioners A
N02BE01 Paracetamol Syrup 120mg/5mL Medical Practitioners A N02BE01 Paracetamol Tablets 500mg Medical Practitioners B
4.6.2 Opioid analgesics
N02AA Codeine Phosphate Tablets 30mg Hospital Doctors N02AA08 Dihydrocodeine Tartrate Tablets 30mg Hospital Doctors N07AC52 Methadone HCl Tablets 5mg Designated Consultant as appointed by DGPHR MP 266 N02AA01 Morphine Sulphate Injection 10mg/mL Hospital Doctors N02AA01 Morphine Sulphate Injection 15mg/mL Hospital Doctors N02AA01 Morphine Sulphate Injection 20mg/mL Hospital Doctors N02AA01 Morphine Sulphate Injection 30mg/mL Hospital Doctors N02AA01 Morphine Sulphate Solution 10mg/5mL Hospital Doctors N02AA01 Morphine Sulphate/Hydrochloride Slow-Release
Tablets 10mg Hospital Doctors
N02AA01 Morphine Sulphate/Hydrochloride Slow-Release Tablets 30mg
Hospital Doctors
N02AA01 Morphine Sulphate/Hydrochloride Slow-Release Tablets 60mg
Hospital Doctors
N02AD01 Pentazocine Tablets 25mg Consultants N02AA01 Pethidine Hydrochloride Tablets 50mg Hospital Doctors N02AX02 Tramadol Capsules 50mg Consultant Physicians, Consultant Surgeons, Consultant
Anaesthetists, Consultant Palliative Care, Consultants Oncologists, Pain Clinic Specialists
MP 192
4.6.3 Neuropathic pain
N02AA09 Amitriptyline (U/L) Syrup 10mg/5mL Consultant Psychiatrists, Consultant Paediatricians, Consultant Oncologists, Consultant Palliative Care
V1.3 March 2012
4. Central Nervous System 19
N02AA09 Amitriptyline (U/L) Tablets 10mg Medical Practitioners B N02AA09 Amitriptyline (U/L) Tablets 25mg Medical Practitioners B N06AA10 Nortriptyline (U/L) Tablets 10mg Medical Practitioners C N06AA10 Nortriptyline (U/L) Tablets 25mg Medical Practitioners C N03AX16 Pregabalin Capsules 75mg Consultant Geriatricians, Consultant Neurologists, Consultant
Psychiatrists MP 160
N03AX16 Pregabalin Capsules 150mg Consultant Geriatricians, Consultant Neurologists, Consultant Psychiatrists
MP 160
N03AX16 Pregabalin Capsules 300mg Consultant Geriatricians, Consultant Neurologists, Consultant Psychiatrists
MP 160
4.6.4 Antimigraine drugs
4.6.4.1 Treatment of acute migraine
N02CA52 Ergotamine Compound Tablets ergotamine 2mg + Cyclizine 50mg + Caffeine 100mg
Hospital Doctors
4.6.4.2 Prophylaxis Treatment of acute migraine
C02AC01 Clonidine Hydrochloride Tablets 100mcg Consultants C
4.7 Antiepileptic drugs
4.7.1 Control of epilepsy
S01EC01 Acetazolamide Tablets 250mg Consultants N03AF01 Carbamazepine Controlled Release
Tablets 200mg Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists, Consultant Geriatricians
N03AF01 Carbamazepine Controlled Release Tablets 400mg
Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists, Consultant Geriatricians
N03AF01 Carbamazepine Syrup 100mg/5mL Medical Practitioners C N03AF01 Carbamazepine Tablets 200mg Medical Practitioners C N05BA09 Clobazam Tablets 10mg Consultant Paediatricians N03AE01 Clonazepam Tablets 0.5mg Medical Practitioners B N03AE01 Clonazepam Tablets 2mg Medical Practitioners B N03AD01 Ethosuximide Syrup 250mg/5mL Consultants N03AD01 Ethosuximide Tablets 250mg Consultants N03AX12 Gabapentin Tablets 100mg Consultant Neurologists, Consultant Paediatricians MP 83 N03AX12 Gabapentin Tablets 300mg Consultant Neurologists, Consultant Paediatricians MP 83 N03AX09 Lamotrigine Dispersible Tablets
5mg Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists
V1.3 March 2012
4. Central Nervous System 20
N03AX09 Lamotrigine Dispersible Tablets 25mg
Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists
N03AX09 Lamotrigine Tablets 25mg Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists
N03AX09 Lamotrigine Tablets 50mg Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists
N03AX09 Lamotrigine Tablets 100mg Consultant Paediatricians, Consultant Neurologists, Consultant Psychiatrists
N03AX14 Levetiracetam Syrup 100mg/mL Consultant Paediatricians, Consultant Neurologists MP 116 N03AX14 Levetiracetam Tablets 500mg Consultant Paediatricians, Consultant Neurologists MP 115 N03AX14 Levetiracetam Tablets 1000mg Consultant Paediatricians, Consultant Neurologists MP 115 N03AA02 Phenobarbital (Phenobarbitone) Mixture Hospital Doctors N03AA02 Phenobarbital (Phenobarbitone) Tablets 30mg Medical Practitioners B N03AB02 Phenytoin Sodium Capsules 25mg Consultants N03AB02 Phenytoin Sodium Capsules 50mg Consultants N03AB02 Phenytoin Sodium Capsules 100mg Consultants N03AB02 Phenytoin Sodium Capsules 300mg Consultants N03AB02 Phenytoin Sodium Syrup 30mg/5mL Consultants N03AX16 Pregabalin Capsules 75mg Consultant Neurologists, Consultant Psychiatrists, Consultant
Geriatricians MP 160
N03AX16 Pregabalin Capsules 150mg Consultant Neurologists, Consultant Psychiatrists, Consultant Geriatricians
MP 160
N03AX16 Pregabalin Capsules 300mg Consultant Neurologists, Consultant Psychiatrists, Consultant Geriatricians
MP 160
N03AA03 Primidone Tablets 250mg Medical Practitioners C N03AF03 Rufinamide Tablets 200mg Consultant Neurologist, Consultant Paediatrician MP 293 N03AG01 Sodium Valproate Controlled Release
Tablets 200mg Consultants
N03AG01 Sodium Valproate Controlled Release Tablets 500mg
Consultants
N03AG01 Sodium Valproate Syrup 200mg/5mL Consultant Paediatricians, Consultant Neurologists, Consultant Geriatricians
N03AX11 Topiramate Tablets 25mg Consultant Neurologists MP 191 N03AX11 Topiramate Tablets 50mg Consultant Neurologists MP 191 N03AX11 Topiramate Tablets 100mg Consultant Neurologists MP 191 N03AX11 Topiramate Tablets 200mg Consultant Neurologists MP 191 N03AG04 Vigabatrin Sachets 500mg Consultant Paediatricians, Consultant Neurologists MP 198 N03AG04 Vigabatrin Tablets 500mg Consultant Paediatricians, Consultant Neurologists MP 197
V1.3 March 2012
4. Central Nervous System 21
4.7.2 Drugs used in status epilepticus
N05BA01 Diazepam Rectal Tubes 5mg/2.5mL
Medical Practitioners B
N05BA01 Diazepam Rectal Tubes 10mg/2.5mL
Medical Practitioners B
4.8 Drugs used in parkinsonism and related disorders
4.8.1 Dopaminergic drugs used in parkinsonism
N04BB01 Amantadine Tablets 100mg Consultants N04BC01 Bromocriptine Mesylate Tablets 2.5mg Consultants N04BA01 Levodopa Tablets 500mg Hospital Doctors N04BA02 Levodopa + Benserazide
Hydrochloride Dispersible Tablets 100mg + 25mg
Consultant Geriatricians, Consultant Neurologists MP 118
N04BA02 Levodopa + Benserazide Hydrochloride
Tablets 50mg + 12.5mg
Medical Practitioners C
N04BA02 Levodopa + Benserazide Hydrochloride
Tablets 100mg + 25mg
Medical Practitioners C
N04BA02 Levodopa + Benserazide Hydrochloride
Tablets 200mg + 50mg
Medical Practitioners C
N04BA02 Levodopa + Carbidopa Tablets 100mg + 10mg
Medical Practitioners C
N04BA02 Levodopa + Carbidopa Tablets 250mg + 25mg
Medical Practitioners C
N04BA03 Levodopa + Carbidopa + Entacapone
Tablets 100mg + 25mg + 200mg
Consultant Geriatricians, Consultant Neurologists MP 216
N04BC04 Non-Ergot Dopamine Receptor Agonists (Ropinirole)
Tablets 250mcg Consultant Geriatricians, Consultant Neurologists MP 215
N04BC04 Non-Ergot Dopamine Receptor Agonists (Ropinirole)
Tablets 1mg Consultant Geriatricians, Consultant Neurologists MP 215
N04BC04 Non-Ergot Dopamine Receptor Agonists (Ropinirole)
Tablets 5mg Consultant Geriatricians, Consultant Neurologists MP 215
N04BD02 Rasagiline Tablets 1mg Consultant Neurologists, Consultant Geriatricians MP 268 N04BD01 Selegiline Tablets 5mg Medical Practitioners C
4.8.2 Antimuscarinic drugs used in parkinsonism
N04AC01 Benzatropine Mesylate Tablets 2mg Medical Practitioners C N04AB02 Orphenadrine Hydrochloride Tablets 50mg Hospital Doctors N04AA04 Procyclidine Injection IM/IV
10mg/2mL Consultant Geriatricians, Consultant Neurologists, Consultant Psychiatrists
V1.3 March 2012
4. Central Nervous System 22
N04AA04 Procyclidine Syrup 5mg/5mL Consultant Geriatricians, Consultant Neurologists, Consultant Psychiatrists
MP 168
N04AA04 Procyclidine Tablets 5mg Consultant Geriatricians, Consultant Neurologists, Consultant Psychiatrists
N04AA01 Trihexyphenidyl Hydrochloride (Benzhexol Hydrochloride)
Tablets 2mg Medical Practitioners C
4.8.3 Drugs used in tremor, chorea, tics and related disorders
N05AD01 Haloperidol Capsules 0.5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AD01 Haloperidol Injections 5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists
N05AD01 Haloperidol Oral Solution 2mg/mL
Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AD01 Haloperidol Tablets 1.5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N05AD01 Haloperidol Tablets 5mg Consultant Psychiatrists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
C
N07XX06 Tetrabenazine Tablets 25mg Consultants C
4.9 Drugs used in substance dependence N07BB01 Disulfiram Tablets 200mg Hospital Doctors C N07BB04 Naltrexone Hydrochloride Tablets 50mg Consultant Psychiatrists MP 142
V1.3 March 2012
5. Infections 23
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
5. Infections 5.1 Antibacterial drugs
5.1.1 Penicillins
J01CA04 Amoxicillin Capsules 250mg Medical Practitioners, GU Clinic Consultants A J01CA04 Amoxicillin Injection 250mg Medical Practitioners A J01CA04 Amoxicillin Injection 500mg Medical Practitioners A J01CA04 Amoxicillin Syrup 125mg/mL Medical Practitioners A J01CR02 Amoxicillin + Clavulanic Acid Syrup 156mg/5mg Medical Practitioners A J01CR02 Amoxicillin + Clavulanic Acid Tablets 250mg +
125mg Medical Practitioners A
J01CE01 Benzylpenicillin Injection 600mg Medical Practitioners A J01CF05 Flucloxacillin Capsules 250mg Medical Practitioners A J01CF05 Flucloxacillin Injection 250mg Medical Practitioners A J01CF05 Flucloxacillin Syrup 125mg/5mL Medical Practitioners A J01CE01 Phenoxymethylpenicillin
(penicillin V) Solution 125mg/5mL
Medical Practitioners C
J01CE02 Phenoxymethylpenicillin (penicillin V)
Tablets 250mg Medical Practitioners C
5.1.2 Cephalosporins
J01DB01 Cefalexin Capsules 250mg Medical Practitioners A J01DB01 Cefalexin Syrup 125mg/5mL Medical Practitioners A J01DC02 Cefuroxime Axetil Suspension
125mg/5mL Medical Practitioners A
J01DC02 Cefuroxime Axetil Tablets 250mg Medical Practitioners A
5.1.3 Tetracyclines
J01AA02 Doxycycline Capsules 100mg Consultants, GU Clinic Consultants J01AA07 Tetracycline Capsules 250mg Medical Practitioners A
V1.3 March 2012
5. Infections 24
5.1.4 Aminoglycosides
J01GB03 Gentamicin Injection 80mg (to be inhaled in cystic fibrosis)
Hospital Doctors TBDF MDHP only
5.1.5 Macrolides
J01FA09 Clarithromycin Syrup 125mg/5mL Consultant Paediatricians J01FA09 Clarithromycin Tablets 250mg Consultants A J01FA01 Erythromycin Syrup 125mg/5mL Medical Practitioners B J01FA01 Erythromycin Tablets 250mg Medical Practitioners, GU Clinic Consultants B
5.1.6 Clindamycin
J01FF01 Clindamycin Capsules 150mg Consultants A
5.1.7 Some other antibacterials
J01BA02 Chloramphenicol Capsules 250mg Consultants A J01XB01 Colistimethate Sodium (Colistin
Sulphomethate Sodium) Injection 1 MU (for inhalation in cystic fibrosis)
Consultant Paediatricians, Consultant Infectious Diseases Physicians, Consultant Respiratory Physicians
MP 44 TBDF MDHP only
J01XC01 Fusidate Sodium Tablets 250mg Consultants A J01XC01 Fusidic Acid Oral Suspension
250mg/5mL Consultants A
A07AA09 Vancomycin Capsules 125mg Consultants MP 281 Initiation in Hospital
5.1.8 Sulphonamides and trimethoprim
J01EE01 Co-Trimoxazole Syrup Adult 480mg/5mL
Medical Practitioners B
J01EE01 Co-Trimoxazole Syrup Paediatric 240mg/5mL
Medical Practitioners B
J01EE01 Co-Trimoxazole Tablets 400mg + 80mg
Medical Practitioners B
J01EC02 Sulfadiazine Tablets 500mg Hospital Doctors J01EA01 Trimethoprim Tablets 100mg Medical Practitioners A
5.1.9 Antituberculosis drugs
J04AB01 Cycloserine Tablets 250mg Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
V1.3 March 2012
5. Infections 25
J04AK02 Ethambutol Tablets 100mg Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
As per AG
J04AK02 Ethambutol Tablets 400mg Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AD03 Ethionamide Tablets 250mg Consultant Infectious Diseases Physicians, Chest Clinic Physicians MP 255 J04AC01 Isoniazid Tablets 100mg Consultant Infectious Diseases Physicians, Paediatric Infectious
Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AM02 Isoniazid + Rifampicin Tablets 100mg + 150mg
Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AM02 Isoniazid + Rifampicin Tablets 150mg + 300mg
Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AD01 Protionamide Tablets 250mg Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AK01 Pyrazinamide Tablets 500mg Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physicians, Consultant Respiratory Physicians, Chest Clinic Physicians
J04AB04 Rifabutin Capsules 150mg Consultant Infectious Diseases Physicians, Chest Clinic Physicians MP 259
J04AB02 Rifampicin Capsules 300mg Consultants MP 174
J04AB02 Rifampicin Syrup 100mg/5mL Consultants MP 174
5.1.10 Antileprotic drugs
J01BA01 Clofazimine Tablets 100mg Consultants J04BA02 Dapsone Tablets 50mg Consultants J04BA02 Dapsone Tablets 100mg Consultants L04AX02 Thalidomide (U/L) Tablets 100mg Consultant Rheumatologists, Consultant Dermatologists,
Consultant Haematologists, Consultant Oncologists
MP 189
V1.3 March 2012
5. Infections 26
5.1.11 Metronidazole
P01AB01 Metronidazole Suppositories 500mg
Medical Practitioners A
P01AB01 Metronidazole Suspension 200mg/5mL
Medical Practitioners A
P01AB01 Metronidazole Tablets 200mg Medical Practitioners, GU Clinic Consultants A
5.1.12 Quinolones
J01MA02 Ciprofloxacin Tablets 250mg Hospital Doctors A J01MA14 Moxifloxacin Tablets 400mg Consultant Infectious Diseases Physicians, Antibiotic Team
Physicians, Consultant Gastroenterologists TBDF MDH only MP 250
J01MA06 Norfloxacin Tablets 400mg Consultants A
5.1.13 Urinary tract infections
J01XE01 Nitrofurantoin Syrup 25mg/5mL Medical Practitioners A J01XE01 Nitrofurantoin Tablets 50mg Medical Practitioners A
5.2 Antifungal drugs J02AC01 Fluconazole Capsules 50mg Consultants MP 72 J02AC01 Fluconazole Capsules 150mg Consultants MP 72 J02AC01 Fluconazole Suspension
50mg/5mL Consultants MP 73
D01BA01 Griseofulvin Tablets 125mg Hospital Doctors A J02AC02 Itraconazole Capsules 100mg Consultant Paediatricians, Consultant Infectious Diseases
Physicians, Consultant Oncologists, Consultant Haematologists, Microbiologists
MP 108
J02AC02 Itraconazole Syrup 10mg/mL Consultant Paediatricians, Consultant Oncologists, Consultant Haematologists, Consultant Infectious Diseases Physicians
MP 107
J02AB02 Ketoconazole Tablets 200mg Hospital Doctors A A07AA02 Nystatin Syrup 100000 IU Medical Practitioners A
5.3 Antivirals
5.3.1 HIV infection
J05AR02 Abacavir + Lamivudine Tablets 600mg + 300mg
Consultant Infectious Diseases Physicians, Consultant Hospital Infection Control Physicians
MP 292
J05AF02 Didanosine Tablets Enteric-Coated 125mg
Consultant Infectious Diseases Physicians MP 53
V1.3 March 2012
5. Infections 27
J05AF02 Didanosine Tablets Enteric-Coated 250mg
Consultant Infectious Diseases Physicians MP 53
J05AG03 Efavirenz Capsules 200mg Consultant Infectious Diseases Physicians MP 208 J05AG03 Efavirenz Tablets 600mg Consultant Infectious Diseases Physicians MP 222 J05AE02 Indinavir Capsules 200mg Consultant Infectious Diseases Physicians MP 97 J05AE02 Indinavir Capsules 400mg Consultant Infectious Diseases Physicians, Hospital Infection
Control MP 96
J05AF05 Lamivudine Oral Solution 10mg/mL
Consultant Paediatricians, Consultant Infectious Diseases Physicians
MP 256
J05AF05 Lamivudine Tablets 100mg Consultant Gastroenterologists, Consultant Infectious Diseases Physicians
MP 110
J05AF05 Lamivudine Tablets 150mg Consultant Infectious Diseases Physicians, Consultant Hospital Infection Control
MP 99
J05AE Lopinavir/Ritonavir Oral Solution 80mg + 20mg per mL
Consultant Infectious Diseases Physicians, Consultant Paediatricians
MP 257
J05AE Lopinavir/Ritonavir Tablets 200mg + 50mg
Consultant Infectious Diseases Physicians, Consultant Hospital Infection Control
MP 221
J05AG01 Nevirapine Oral suspension 50mg/5mL
Consultant Paediatricians, Consultant Infectious Diseases Physicians
MP 258
J05AG01 Nevirapine Tablets 200mg Consultant Infectious Diseases Physicians MP 143 J05AE03 Ritonavir Capsules 100mg Consultant Infectious Diseases Physicians MP 176 J05AE01 Saquinavir Capsules 500mg Consultant Infectious Diseases Physicians MP 178 J05AF04 Stavudine Capsules 30mg Consultant Infectious Diseases Physicians MP 182 J05AF04 Stavudine Capsules 40mg Consultant Infectious Diseases Physicians MP 182 J05AF07 Tenofovir Tablets 245mg Consultant Infectious Diseases Physicians MP 187 J05AF01 Zidovudine (Azidothymidine) Capsules 100mg Consultant Infectious Diseases Physicians, Hospital Infection
Control MP 203
J05AF01 Zidovudine (Azidothymidine) Oral Solution 100mg/10mL
Consultant Paediatricians, Consultant Infectious Diseases Physicians, Paediatric Infectious Diseases Clinic Physician
MP 202
J05AR01 Zidovudine + Lamivudine Tablets 300mg + 150mg
Consultant Infectious Diseases Physicians, Consultant Hospital Infection Control Physicians
MP 209
5.3.2 Herpesvirus infections
5.3.2.1 Herpes simplex and varicella-zoster infection
J05AB01 Aciclovir (Acyclovir) Suspension 200mg/5mL
Consultants (for Schedule V holders only), Consultant Dermatologists (for Pink Card holders)
MP 3 A
V1.3 March 2012
5. Infections 28
J05AB01 Aciclovir (Acyclovir) Tablets 200mg Consultants (for Schedule V holders only), Consultant Dermatologists (for Pink Card holders), GU Clinic Consultants
MP 2 A
J05AB01 Aciclovir (Acyclovir) Tablets 800mg Consultants (for Schedule V holders only), Consultant Dermatologists (for Pink Card holders)
MP 2 A
5.3.2.2 Cytomegalovirus infection
J05AB14 Valganciclovir Tablets 450mg Consultant Infectious Diseases Physicians, Consultant Nephrologists, Consultant Cardiac Surgeons, Consultant Gastroenterologists
MP 247
5.4 Antiprotozoal drugs
5.4.1 Antimalarials
P01BA01 Chloroquine Syrup 50mg/5mL Medical Practitioners (for missionaries or on payment) P01BA01 Chloroquine Syrup 150mg
base/5mL Medical Practitioners (for missionaries or on payment)
P01BA01 Chloroquine Tablets 250mg Medical Practitioners (for missionaries or on payment) P01BC02 Mefloquine Tablets 250mg Medical Practitioners (for missionaries or on payment) P01BB01 Proguanil Hydrochloride Tablets 100mg Medical Practitioners (for missionaries or on payment) P01BB51 Proguanil Hydrochloride +
Atovaquone (stand-by) Tablets 100mg + 250mg
Medical Practitioners (for missionaries or on payment)
P01BD01 Pyrimethamine Tablets 25mg Hospital Doctors P01BD51 Pyrimethamine + Sulphadoxine Tablets 25mg +
500mg Hospital Doctors
5.4.2 Antigiardial drugs
P01AX05 Mepacrine Hydrochloride (U/L) Tablets 100mg Consultant Physicians MP 123 P01AX11 Nitazoxanide Tablets 500mg Antibiotic Team Physicians, Infectious Diseases Physician,
Consultant Gastroenterologists
P01AX11 Nitazoxanide Syrup 100mg/5mL Antibiotic Team Physicians, Infectious Diseases Physician, Consultant Gastroenterologists
5.5 Antihelmintics
5.5.1 Drugs for threadworms
P02CA01 Mebendazole Suspension 2% Consultants P02CA01 Mebendazole Tablets (chewable)
100mg Consultants
5.5.2 Ascaricides
P02CA01 Mebendazole Suspension 2% Consultants P02CA01 Mebendazole Tablets (chewable)
100mg Consultants
V1.3 March 2012
5. Infections 29
5.5.3 Drugs for tapeworm infections
P02CA03 Albendazole Tablets 400mg Consultants P02DA01 Niclosamide (U/L) Tablets 0.5g Consultant Infectious Diseases Physicians P02BA01 Praziquantel Tablets 500mg Consultant Infectious Diseases Physicians A
5.5.4 Drugs for hookworms
P02CA03 Albendazole Tablets 400mg Consultants P02CA01 Mebendazole Tablets (chewable)
100mg Consultants
P02CA01 Mebendazole Suspension 2% Consultants
5.5.5 Schistosomides (Bilharzias)
P02BA01 Praziquantel Tablets 500mg Consultant Infectious Diseases Physicians A
5.5.6 Filaricides
P02CF01 Ivermectin Tablets 3mg Consultants, Senior Public Health Physicians A
5.5.7 Drugs for cutaneous larva migrans
P02CA03 Albendazole Tablets 400mg Consultants P02CF01 Ivermectin Tablets 3mg Consultants, Senior Public Health Physicians A
5.5.8 Drugs for strongyloidiasis
P02CA03 Albendazole Tablets 400mg Consultants P02CF01 Ivermectin Tablets 3mg Consultants, Senior Public Health Physicians A
V1.3 March 2012
6. Endocrine System 30
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
6. Endocrine system 6.1 Drugs used in diabetes
6.1.1 Insulins
6.1.1.1 Short-acting insulins
A10AB05 Insulin Aspart Cartridge 100IU/mL in 3mL
Consultant Endocrinologists MP 207
A10AB01 Insulin Neutral (Soluble Insulin) Cartridge 100units/mL in 3mL
Consultant Endocrinologists MP 100
A10AB01 Insulin Neutral (Soluble Insulin) Injection SC 100IU/mL in 10mL
Consultant Endocrinologists
6.1.1.2 Intermediate- and long-acting insulins
A10AD01 Insulin Biphasic Isophane (Isophane + Neutral)
Cartridges (70%. 30%) 100IU/mL
Consultant Endocrinologists MP 100
A10AD01 Insulin Biphasic Isophane (Isophane + Neutral)
Injection 100IU/mL Consultant Endocrinologists
A10AE04 Insulin Glargine Cartridge 100IU/mL Consultant Endocrinologists MP 101 A10AC01 Insulin Isophane Cartridge 100
units/mL in 3mL Consultant Endocrinologists MP 100
A10AC01 Insulin Isophane Injection 100 IU/mL in 10mL
Consultant Endocrinologists
6.1.2 Antidiabetic drugs
6.1.2.1 Sulphonylureas
A10BB01 Glibenclamide Tablets 5mg Medical Practitioners A10BB09 Gliclazide Tablets 80mg Consultants
6.1.2.2 Biguanides
A10BA02 Metformin Tablets 500mg Medical Practitioners
6.1.3 Treatment of hypoglycaemia
H04AA01 Glucagon Injection 1mg Consultant Endocrinologists
V1.3 March 2012
6. Endocrine System 31
6.2 Thyroid and antithyroid drugs
6.2.1 Thyroid hormones
H03AA01 Levothyroxine (Thyroxine) Tablets 50mcg Medical Practitioners C H03AA01 Levothyroxine (Thyroxine) Tablets 100mcg Medical Practitioners C H03AA02 Liothyronine Sodium (L-Tri-
iodothyronine) Tablets 20mcg Consultants MP 242
6.2.2 Antithyroid drugs
H03BB01 Carbimazole Tablets 5mg Medical Practitioners C H03BA02 Propylthiouracil Tablets 50mg Medical Practitioners C
6.3 Corticosteroids
6.3.1 Replacement therapy
H02AA02 Fludrocortisone Acetate Tablets 0.1mg Hospital Doctors
6.3.2 Glucocorticoid therapy
H02AB10 Cortisone Acetate Tablets 25mg Medical Practitioners C H02AB02 Dexamethasone Tablets 0.5mg Medical Practitioners C H02AB02 Dexamethasone Tablets 2mg Consultants H02AB09 Hydrocortisone Tablets 10mg
(Quarter Scored) Consultant Paediatricians, Consultant Physicians
H02AB09 Hydrocortisone Tablets 20mg Consultants C H02AB09 Hydrocortisone Sodium Succinate Injection 100mg Consultants TBDF MDH
only
H02AB04 Methylprednisolone Tablets 4mg Consultant Dermatologists H02AB04 Methylprednisolone Acetate Injection IM
40mg/mL Consultants
H02AB04 Methylprednisolone Sodium Succinate
Injection 500mg Consultants
H02AB04 Methylprednisolone Sodium Succinate
Injection IM/IV 40mg Consultants
H02AB06 Prednisolone Tablets 1mg Medical Practitioners B H02AB07 Prednisolone Tablets 5mg Medical Practitioners, GU Clinic Consultants B H02AB08 Prednisolone Tablets enteric-
coated 5mg Medical Practitioners B
V1.3 March 2012
6. Endocrine System 32
6.4 Sex hormones
6.4.1 Female sex hormones
6.4.1.1 Estrogens and HRT
G03CA57 Conjugated Estrogens Cream 625mcg/g Consultants C G03CA57 Conjugated Estrogens (Equine) Tablets 0.625mg Consultants C G03CA57 Conjugated Estrogens (Equine) Tablets 1.25mg Consultants C G03CA03 Estradiol Valerate Tablets 1mg Consultant Obstetricians & Gynaecologists C G03CA03 Estradiol Valerate Tablets 2mg Consultant Obstetricians & Gynaecologists C G03FA10 Estradiol Valerate + Norgestrel Tablets 2mg +
0.5mg Consultant Endocrinologists, Consultant Oncologists, Consultant Haematologists
MP 234
G03CA01 Ethinylestradiol Tablets 10mcg Consultant Paediatricians, Consultant Endocrinologists MP 235
6.4.1.2 Progesterone
G03DB01 Dydrogesterone Tablets 10mg Consultants B G03AC06 Medroxyprogesterone Acetate Injection 150mg/mL
in 1mL Consultant Oncologists, Consultant Obstetricians & Gynaecologists
G03DA02 Medroxyprogesterone Acetate Tablets 5mg Hospital Doctors G03DC02 Norethisterone Tablets 5mg Hospital Doctors B
6.4.2 Male sex hormones and antagonists
G03BA03 Testosterone Enanthate Depot Injection 250mg Consultant Paediatricians, Consultant Endocrinologists, Consultant Oncologists
MP 188
G03BA03 Testosterone Undecanoate Injection 1000mg/4mL
Consultant Endocrinologists MP 279
G04CB01 Finasteride Tablets 5mg Consultant Urologists C
6.5 Hypothalamic and pituitary hormones and anti-estrogens
6.5.1 Hypothalamic and anterior pituitary hormones and anti-estrogens
G03GA01 Chorionic Gonadotrophin (HCG) Injection 1000 IU Consultants G03GA01 Chorionic Gonadotrophin (HCG) Injection 5000 IU Consultants G03GB02 Clomifene Citrate Tablets 50mg Consultant Obstetricians & Gynaecologists H01AC01 Growth Hormone Recombinant Injection Consultant Paediatricians, Consultant Endocrinologists MP 88 L02BA01 Tamoxifen Tablets 20mg Medical Practitioners C
6.5.2 Posterior pituitary hormones and antagonists
J01AA01 Demeclocycline Hydrochloride Capsules 150mg Consultant Physicians HP 49 H01BA02 Desmopressin Intranasal Solution
100mcg/mL Consultants C
V1.3 March 2012
6. Endocrine System 33
H01BA02 Desmopressin Nasal Spray 10mcg Consultant Endocrinologists, Consultant Paediatricians, Consultant Nephrologists, Consultant Oncologists
MP 50
H01BA02 Desmopressin Tablets 0.1mg Consultant Endocrinologists, Consultant Paediatricians, Consultant Nephrologists, Consultant Oncologists
MP 51
6.6 Drugs affecting bone metabolism
6.6.1 Calcitonin
H05BA01 Calcitonin (Salmon Synthetic) Injection 100IU/mL Consultants C H05AA02 Teriparatide Pre-Filled Pen
20mcg/80mcL Consultant Rheumatologists MP 190
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
M05BA01 Disodium Etidronate Tablets 200mg Consultant Physicians MP 55 M05BA02 Clodronate Tablets 400mg Consultant Oncologists, Consultant Haematologists MP 41 M05BA08 Zoledronic Acid Vials 4mg Consultants MP 228 M05BA08 Zoledronic Acid Vials 5mg Consultants MP 229
6.7 Other endocrine drugs
6.7.1 Bromocriptine and other dopaminergic drugs
G02CB01 Bromocriptine Mesylate Tablets 2.5mg Medical Practitioners G02CB03/ N04BC06
Cabergoline Tablets 0.5mg Consultant Physicians MP 29
G02CB02 Lisuride Maleate (Lysuride) Tablets 0.2mg Consultant Physicians MP 121
6.7.2 Drugs affecting gonadotrophins
L02AE03 Goserelin Implants 3.6mg Consultant Obstetricians & Gynaecologists, Consultant Oncologists MP 86 L02AE03 Goserelin Implants 10.8mg Consultant Oncologists, Consultant Urologists MP 87 L02AE02 Leuprorelin Injections 3.75mg Consultant Paediatricians, Consultant Endocrinologists MP 114
V1.2 March 2012
7. Obstetrics, gynaecology, and urinary-tract disorders 34
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
7. Obstetrics, gynaecology, and urinary-tract disorders 7.1 Treatment of vaginal and vulval conditions
7.1.1 Vaginal and vulval infections
D01AC01 Clotrimazole Cream 1% Medical Practitioners A G01AF02 Clotrimazole Pessaries 100mg Medical Practitioners, GU Clinic Consultants A G01AF05 Econazole Pessaries 150mg Consultants A G01AA01 Nystatin Vaginal Cream
100000 IU/4g Medical Practitioners A
7.2 Drugs for Genitor-urinary disorders
7.2.1 Drugs for urinary retention
M07AA02 Distigmine Bromide Tablets 5mg Hospital Doctors C C02CA04 Doxazosin Tablets 1mg Consultants C02CA04 Doxazosin Tablets 2mg Consultants C
(Consultant urologist)
C02CA04 Doxazosin Tablets 4mg Consultants C02CA01 Prazosin Tablets 500mcg Consultant Physicians, Consultant Cardiologists, Consultant
Cardiac Surgeons MP 166
7.2.2 Drugs for urinary frequency, enuresis and incontinence
G04BD02 Flavoxate Tablets 200mg Consultant Physicians C G04BD04 Oxybutynin Hydrochloride Syrup 2.5mg/5mL Consultants C G04BD04 Oxybutynin Hydrochloride Tablets 5mg Consultants C
7.2.3 Drugs used in urological pain
A12BA02 Potassium Citrate Mixture 1.5g/5mL Consultant Nephrologists, Consultant Urologists, Consultant Paediatricians
V1.3 March 2012
8. Malignant disease and immunosuppression 35
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
8. Malignant disease and immunosuppression 8.1 Cytotoxic drugs
V03AF03 Calcium Folinate (Leucovorin/Folinic Acid)
Tablets 15mg Hospital Doctors
8.1.1 Alkylating drugs
L01AB01 Busulfan Tablets 2mg Consultant Oncologists, Consultant Haematologists, Consultant Paediatricians
L01AA01 Chlorambucil Tablets 2mg Consultants L01AA01 Cyclophosphamide Tablets 50mg Consultants L01AD02 Lomustine Capsules 40mg Consultant Oncologists, Consultant Haematologists, Consultant
Paediatricians
L01AA03 Melphalan Tablets 2mg Consultants
8.1.2 Antimetabolites
L01BB05 Fludarabine Capsules 10mg Consultant Oncologists, Consultant Haematologists, Consultant Paediatricians
MP 74
L01BC02 Fluorouracil Cream 5% Consultant Dermatologists, Consultant Oncologists L01BB02 Mercaptopurine Tablets 50mg Consultants L01BA01 Methotrexate Tablets 2.5mg Consultants L01BB03 Tioguanine (U/L) Tablets 40mg Consultant Oncologists, Consultant Haematologists, Consultant
Paediatricians
8.1.3 Etoposide
L01CB01 Etoposide Capsules 50mg Consultant Oncologists, Consultant Haematologists, Consultant Paediatricians
8.1.4 Other antineoplastic drugs
L01XX25 Bexarotene Capsules 75mg Consultant Oncologists MP 18 L01XE03 Erlotinib Tablets 150mg Consultant Oncologists MP 262
V1.3 March 2012
8. Malignant disease and immunosuppression 36
L01XX05 Hydroxycarbamide (Hydroxyurea) Capsules 500mg Consultant Oncologists, Consultant Haematologists, Consultant Paediatricians, Thalassaemia Clinic Consultants
C
L01XE01 Imatinib Capsules 100mg Consultant Oncologists, Consultant Haematologists, Consultant Paediatricians
MP 95
L01XB01 Procarbazine Capsules 50mg Consultants L01XE04 Sunitinib Capsules 12.5mg Consultant Oncologists MP 264 L01XE04 Sunitinib Capsules 50mg Consultant Oncologists MP 264 L01AX03 Temozolomide Capsules 5mg Consultant Oncologists MP 265 L01AX03 Temozolomide Capsules 20mg Consultant Oncologists MP 265 L01AX03 Temozolomide Capsules 100mg Consultant Oncologists MP 265 L01AX03 Temozolomide Capsules 140mg Consultant Oncologists MP 265 L01XX14 Tretinoin Capsules 10mg Consultant Oncologists
8.2 Drugs affecting the immune response
8.2.1 Antiproliferative immunosuppressants
L04AX01 Azathioprine Tablets 50mg Hospital Doctors L04AA06 Mycophenolate Mofetil Syrup Consultant Nephrologists, Consultant Paediatricians, Consultant
Cardiac Surgeons, Consultant Gastroenterologists MP 141
L04AA06 Mycophenolate Sodium Gastro-Resistant Tablets 180mg
Consultant Nephrologists MP 140
L04AA06 Mycophenolate Sodium Gastro-Resistant Tablets 360mg
Consultant Nephrologists MP 140
8.2.2 Corticosteroids and other immunosuppressants
L04AD01 Ciclosporin (Cyclosporin) Capsules 25mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Capsules 100mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Oral Solution
100mg/mL Consultant Nephrologists, Consultant Dermatologists, Consultant Rheumatologists, Consultant Paediatricians, Consultant Haematologists, Consultant Cardiac Surgeons
MP 47
L04AA06 Sirolimus Syrup 1mg/mL Consultant Nephrologists MP 230 L04AA06 Sirolimus Tablets 1mg Consultant Nephrologists MP 231 L04AD02 Tacrolimus Tablets 0.5mg Consultant Gastroenterologists, Consultant Paediatricians MP 210 L04AD02 Tacrolimus Tablets 1mg Consultant Gastroenterologists, Consultant Paediatricians MP 210 L04AD02 Tacrolimus Tablets 5mg Consultant Gastroenterologists, Consultant Paediatricians MP 210
8.2.3 Other immunomodulating drugs
L03AB05 Interferon Alfa 2b Injection 30M IU Consultant Gastroenterologists, Consultant Haematologists, Consultant Infectious Diseases Physicians, Consultant Oncologists
MP 102
V1.3 March 2012
8. Malignant disease and immunosuppression 37
L03AB07 Interferon Beta 1a Injection 30mcg (6M IU)
Consultant Neurologists
L03AB07 Interferon Beta 1b Injection 9.6M IU Consultant Neurologists L03AB03 Interferon Gamma Injection 100mcg Consultant Paediatricians, Consultant Respiratory Physicians,
Consultant Infectious Diseases Physicians MP 104
L01AX04 Lenalidomide Capsules 25mg Consultant Oncologists, Consultant Haematologists MP 263
L04AX02 Thalidomide (U/L) Tablets 100mg Consultant Rheumatologists, Consultant Dermatologists, Consultant Haematologists, Consultant Oncologists
MP 189
8.3 Sex hormones and hormone antagonists in malignant diseases
8.3.1 Estrogens
G03CB02/ L02AA01
Diethylstilbestrol (Stilboestrol) Tablets 1mg Consultants C
G03CB02/ L02AA01
Diethylstilbestrol (Stilboestrol) Tablets 5mg Consultants C
G03CA01 Ethinylestradiol Tablets 10mcg Consultant Paediatricians, Consultant Endocrinologists MP 235
8.3.2 Progestogens
L02AB02 Medroxyprogesterone Acetate Tablets 100mg Consultants
8.3.3 Hormone antagonists
8.3.3.1 Breast cancer
L02BG03 Anastrozole Tablets 1mg Consultant Oncologists MP 8 L02BG03 Letrozole Tablets 2.5mg Consultant Oncologists MP 254 L02BA01 Tamoxifen Tablets 20mg Medical Practitioners C
8.3.3.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists
L02BB03 Bicalutamide Tablets 50mg Consultant Urologists, Consultant Oncologists MP 19 G03HA01 Cyproterone Acetate Tablets 50mg Consultants L02BB01 Flutamide Tablets 250mg Consultant Oncologists, Consultant Urologists MP 76
8.3.3.3 Somatostatin analogues
H01CB02 Octreotide Injection 200mcg/mL (multidose)
Consultant Gastroenterologists, Consultant Surgeons, Consultant Oncologists, Consultant Palliative Care
MP 147
H01CB02 Octreotide Long Acting Injection IM 10mg Consultant Endocrinologists, Consultant Oncologists MP 149
V1.3 March 2012
8. Malignant disease and immunosuppression 38
H01CB02 Octreotide Long Acting Injection IM 20mg Consultant Endocrinologists, Consultant Oncologists MP 149
H01CB02 Octreotide Long Acting Injection IM 30mg Consultant Endocrinologists, Consultant Oncologists MP 149
V1.3 March 2012
9. Nutrition and blood 39
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
9. Nutrition and blood 9.1 Anaemias and some other blood disorders
9.1.1 Iron-deficiency anaemias
9.1.1.1 Oral iron
B03AD02 Iron + folic acid Tablets/Capsules Medical Practitioners B B03AA03 Ferrous Gluconate Tablets 300mg Medical Practitioners B B03AA07 Ferrous Sulphate Tablets 325mg Medical Practitioners B B03AB03 Sodium Feredetate (oral iron) Solution
190mg/5mL equivalent to 27.5mg iron
Medical Practitioners B
9.1.2 Drugs used in megaloblastic anaemias
B03BB01 Folic Acid Oral solution 2.5mg/mL
Consultant Paediatricians, Consultant Rheumatologists MP 80
B03BB01 Folic Acid Tablets 5mg Medical Practitioners B B03BA03 Hydroxycobalamin (Vitamin B12) Injection 1mg/mL Medical Practitioners C
9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias
V03AC03 Deferasirox Dispersible tablets 250mg
Thalassaemia Clinic Consultants, Consultant Haematologists MP 277
V03AC03 Deferasirox Dispersible tablets 500mg
Thalassaemia Clinic Consultants, Consultant Haematologists MP 277
B03XA01 Recombinant Human Erythropoietin
Prefilled syringe 2000 IU
Consultant Gastroenterologists, Consultant Nephrologists, Consultant Paediatricians
MP 65
B03XA01 Recombinant Human Erythropoietin
Prefilled syringe 3000 IU
Consultant Gastroenterologists, Consultant Nephrologists, Consultant Paediatricians
MP 65
B03XA01 Recombinant Human Erythropoietin
Prefilled syringe 4000 IU
Consultant Gastroenterologists, Consultant Nephrologists, Consultant Paediatricians
MP 65
V1.3 March 2012
9. Nutrition and blood 40
9.1.4 Drugs used in neutropenia L03AA02 Filgrastim (Rec. Human G-CSF) Injection 30 MIU Consultant Oncologists, Consultant Haematologists, Consultant
Paediatricians, Consultant Infectious Diseases Physician HP 69 HU/HDO
9.2 Fluids and electrolytes
9.2.1 Oral preparations for fluid and electrolyte imbalance
9.2.1.1 Oral potassium
V03AE01 Calcium Polystyrene Sulphonate (Calcium Resonium) )
Powder Consultants
A12BA01 Potassium Chloride Syrup 1mmol/mL (7.5%)
Medical Practitioners C
A12BA01 Potassium Chloride Tablets 600mg (8mmol)
Medical Practitioners C
A12BA Potassium Supplement Effervescent Tablets Consultants
9.2.1.2 Oral sodium and water
A07CA Oral Rehydration Powder Medical Practitioners A
9.2.1.3 Oral bicarbonate
B05XA02 Sodium Bicarbonate Pre-filled syringe 8.4% in 50mL
Hospital Doctors HU/HDO for oral use
A12AX Sodium Bicarbonate Tablets 500/600mg Hospital Doctors C
9.2.2 Parenteral preparations for fluid and electrolyte imbalance
9.2.2.1 Electrolytes and water B05B Water for injection Ampoule 5mL Hospital Doctors TBDF
MDHP only with Colistim- ethate sodium
9.3 Minerals
9.3.1 Calcium and magnesium
9.3.1.1 Calcium supplements
A12AA04 Calcium Tablets Effervescent 400-500mg
Consultant Paediatricians, Consultant Physicians MP 30
A12AA04 Calcium Carbonate Tablets 500mg Consultants A12AA05 Calcium Lactate Tablets 300mg Medical Practitioners C
V1.3 March 2012
9. Nutrition and blood 41
9.3.1.2 Magnesium
A12CC Magnesium Glycerophosphate (U/L)
Tablets 97.2mg (4mmol)
Consultant Paediatricians, Consultant Gastroenterologists, Consultant Nephrologists
MP 122
9.3.2 Phosphorus
9.3.2.1 Phosphate supplements
A12CX Phosphate Supplement Tablets Effervescent Consultant Paediatricians, Consultant Physicians MP 165
9.3.2.2 Phosphate-Binding agents V03AE03 Lanthanum Chewable tablets
750mg Consultant Nephrologists MP 273
9.4 Vitamins
9.4.1 Vitamin A
A11CA01 Vitamin A (Retinol) Tablets 50,000 IU Hospital Doctors A11CB Vitamin A + D Tablets 4000 IU +
400 IU Medical Practitioners A
9.4.2 Vitamin B group
A11HA01 Nicotinamide Tablets 250mg Consultant Dermatologists MP 145 A11HA02 Pyridoxine (Vitamin B6) Tablets 10mg Medical Practitioners C
A11HA02 Pyridoxine (Vitamin B6) Tablets 50mg Medical Practitioners C A11DA01 Thiamine (Vitamin B1) Tablets 50mg Medical Practitioners C
A11EA Vitamin B Complex (Nicotinamide + Riboflavin + Thiamine)
Tablets 15mg + 1mg + 1mg
Medical Practitioners B
9.4.3 Vitamin C
A11GA01 Ascorbic Acid Tablets Medical Practitioners B
9.4.4 Vitamin D
A11CC03 Alfacalcidol (1-α Hydroxyvitamin D3)
Tablets 0.25mcg Consultants C
A11CC03 Alfacalcidol (1-α Hydroxyvitamin D3)
Tablets 1mcg Consultants
A11CC03 Alfacalcidol (1-α Hydroxyvitamin D3)
Oral Drops 2mcg/mL
Consultants MP 5
A11CC01 Calciferol Tablets 0.25mg Medical Practitioners C
9.4.5 Vitamin E
A11HA03 Alpha Tocopheryl (Vitamin E) Suspension 100mg/mL
Consultant Paediatricians, Consultant Gastroenterologists, Consultant Respiratory Physicians, Consultant Endocrinologists
MP 199
V1.3 March 2012
9. Nutrition and blood 42
A11HA03 Alpha Tocopheryl (Vitamin E) Tablets 50-150mg (134mg)
Consultant Paediatricians, Consultant Gastroenterologists, Consultant Respiratory Physicians, Consultant Endocrinologists
MP 200
A11HA03 Alpha Tocopheryl (Vitamin E) Tablets 670mg (1000 IU)
Consultant Paediatricians, Consultant Gastroenterologists, Consultant Respiratory Physicians, Consultant Endocrinologists
MP 200
9.4.6 Vitamin K
B02BA02 Menadiol Sodium Phosphate Tablets 10mg Consultants B02BA01 Phytomenadione (Vitamin K1) Injection 10mg/mL
in 0.2mL Hospital Doctors HU/HDO
for oral use
9.4.7 Multivitamin preparations
A11BA Multivitamins Injection IV Hospital Doctors A11BA Multivitamins Syrup Medical Practitioners A A11BA Multivitamins (Abidec®) Drops Consultant Paediatricians MP 135 A11BA Multivitamins (Cernevit™-12) Infusion Consultants MP 138 A11AA03 Multivitamins + mineral preparation
(Ketovite®) Syrup Consultant Paediatricians, Consultant Physicians, Consultant
Gastroenterologists MP 137
A11AA03 Multivitamins + mineral preparation (Ketovite®)
Tablets Consultant Paediatricians, Consultant Physicians, Consultant Gastroenterologists
MP 136
V1.3 March 2012
10. Musculoskeletal and joint diseases 43
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
10. Musculoskeletal and joint diseases 10.1 Drugs used in rheumatic diseases and gout
10.1.1 Non-Steroidal anti-inflammatory drugs
M01AC06 Cox-2 Selective Inhibitor (currently meloxicam)
Tablets Consultant Rheumatologists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians
MP 45
M01AB05 Diclofenac Sodium Suppositories 12.5mg
Consultant Paediatricians A
M01AB05 Diclofenac Sodium Suppositories 100mg
Medical Practitioners A
M01AB05 Diclofenac Sodium Tablets 25mg Medical Practitioners B M01AE01 Ibuprofen Oral Suspension
100mg/5mL Consultant Paediatricians, Consultant Paediatric Surgeons, Consultant Oncologists, Consultant Palliative Care, Consultant Rheumatologists
MP 92
M01AE01 Ibuprofen Tablets 200mg Medical Practitioners B M01AB01 Indometacin Capsules 25mg Medical Practitioners B M01AB01 Indometacin Suppositories
100mg Medical Practitioners B
M01AG01 Mefenamic Acid Capsules 250mg Medical Practitioners B M01AE02 Naproxen Tablets 250mg Medical Practitioners B M01AC01 Piroxicam Tablets 10mg Consultants C
10.1.2 Corticosteroids
10.1.2.1 Local corticosteroids injections
H02AB04 Methylprednisolone Acetate Injection IM 40mg/mL
Consultants
10.1.3 Drugs that suppress the rheumatic disease process
L04AX01 Azathioprine Tablets 50mg Hospital Doctors L04AD01 Ciclosporin (Cyclosporin) Capsules 25mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Capsules 100mg Consultants MP 46
V1.3 March 2012
10. Musculoskeletal and joint diseases 44
L04AD01 Ciclosporin (Cyclosporin) Oral Solution 100mg/mL
Consultants MP 47
L04AB01 Etanercept Injection 25mg Consultant Rheumatologists MP 66 L04AB01 Etanercept Injection 50mg Consultant Rheumatologists MP 66 P01BA02 Hydroxychloroquine Sulphate Tablets 200mg Consultants L04AA13 Leflunomide Tablets 10mg, 20mg Consultant Rheumatologists MP 113 L01BA01 Methotrexate Tablets 2.5mg Consultants M01CC01 Penicillamine Tablets 250mg Consultants C A07EC01 Sulfasalazine Tablets 500mg Consultant Gastroenterologists, Consultant Paediatricians,
Consultant Surgeons, Consultant Rheumatologists
10.1.4 Gout and cytotoxic induced hyperuricaemia
M04AA01 Allopurinol Tablets 100mg Medical Practitioners C M04AA01 Allopurinol Tablets 300mg Medical Practitioners C M04AC01 Colchicine Tablets 500mcg Medical Practitioners C M04AB02 Sulfinpyrazone Tablets 200mg Consultants C
10.2 Drugs used in neuromuscular disorders
10.2.1 Drugs that enhance neuromuscular transmission
M07AA02 Distigmine Bromide Tablets 5mg Hospital Doctors C M07AA02 Pyridostigmine Bromide Tablets 60mg Hospital Doctors
10.2.2 Skeletal muscle relaxants
M03BX01 Baclofen Syrup 5mg/5mL Consultant Paediatricians, Consultant Neurologists, Consultant Palliative Care, Consultant Oncologists, Consultant Geriatricians, Consultant Anaesthetists, Pain Clinic Specialists
MP 14
M03BX01 Baclofen Tablets 10mg Consultants M03BX01 Baclofen Tablets 25mg Consultants M03CA01 Dantrolene Sodium Capsules 25mg Consultants N05BA01 Diazepam Syrup 2mg/5mL Medical Practitioners B N05BA01 Diazepam Tablets 2mg Medical Practitioners B N05BA01 Diazepam Tablets 5mg Medical Practitioners B
V1.3 March 2012
11. Eye 45
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
11. Eye 11.1 Anti-infective eye preparations
11.1.1 Antibacterials
S01AA01 Chloramphenicol Eye Drops 0.5% Medical Practitioners A S01AA01 Chloramphenicol Eye Ointment 1% Medical Practitioners A S03AA06 Framycetin + Dexamethasone +
Gramicidin Eye/Ear Drops 0.3% Medical Practitioners A
11.1.2 Antivirals
S01AD03 Aciclovir (Acyclovir) Eye Ointment 3% Consultant Ophthalmologists A
11.2 Corticosteroids and anti-inflammatory preparations
11.2.1 Corticosteroids
S01BA06 Betamethasone Sodium Phosphate
Eye Drops 0.1% Medical Practitioners A
S01BA01 Dexamethasone Eye Drops 0.1% Medical Practitioners A S01BA02 Hydrocortisone Acetate Eye Ointment 1% Hospital Doctors A S01BA04 Prednisolone Sodium Phosphate Eye Drops 0.5% Consultants A
11.2.2 Other anti-inflammatory preparations
S01XG01 Sodium Cromoglicate Eye Drops 2% Medical Practitioners A
11.3 Mydriatics and cycoplegics S01FA01 Atropine Sulphate Eye Drops 1% Consultants S01FA04 Cyclopentolate Hydrochloride Eye Drops 1% Consultant Ophthalmologists C S01FA06 Tropicamide Eye Drops 0.5% Consultant Ophthalmologists
11.4 Treatment of glaucoma S01EC01 Acetazolamide Tablets 250mg Consultants S01ED02 Betaxolol Hydrochloride Eye Drops 0.25% Consultant Ophthalmologists S01ED02 Betaxolol Hydrochloride Eye Drops 0.5% Consultant Ophthalmologists
V1.3 March 2012
11. Eye 46
S01AA01 Brimonidine Tartrate Eye drops 0.2% Consultant Ophthalmologists S01EC03 Carbonic Anhydrase Inhibitors
(Currently Dorzolamide) Eye drops Consultant Ophthalmologists
S01ED04 Beta-Blocker preservative free (Timolol, Betaxolol or Levobunolol)
Eye Drops Consultant Ophthalmologists MP 127
S01EB01 Pilocarpine Hydrochloride Eye drops 1% Medical Practitioners C S01EB01 Pilocarpine Hydrochloride Eye drops 2% Medical Practitioners C S01EB01 Pilocarpine Hydrochloride Eye drops 4% Medical Practitioners C S01EE04 Prostaglandin Analogues
(Currently Latanoprost) Eye drops Consultant Ophthalmologists
S01EE04 Travoprost Eye drops Consultant Ophthalmologists MP 194 S01ED01 Timolol Maleate Eye Drops 0.25% Medical Practitioners C S01ED01 Timolol Maleate Eye Drops 0.5% Medical Practitioners C
11.5 Miscellaneous ophthalmic preparations
11.5.1 Tear deficiency, ocular lubricants, and astringents
S01XA08 Acetylcysteine Eye Drops 5% Consultant Ophthalmologists MP 205 S01KA02 Hypromellose Eye Drops 0.3% Medical Practitioners B
V1.3 March 2012
12. Ear, nose and oropharynx 47
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
12. Ear, nose and oropharynx 12.1 Drugs acting on the ears
12.1.1 Otitis externa
S03CA01 Dexamethasone + Framycetin + Gramicidin
Ear/Eye Drops 0.05% + 0.5% + 0.005%
Medical Practitioners A
S02CA02 Flumethasone + Clioquinol Ear Drops 0.02% + 1%
Medical Practitioners A
S03AA06 Gentamicin Ear/Eye Drops 0.3% Medical Practitioners A S02CA03 Hydrocortisone + Gentamicin Ear Drops 1% +
0.3% Medical Practitioners A
S02CA03 Hydrocortisone + Polymyxin B + Neomycin
Ear Drops 10mg/mL + 10,000 IU + 3400 IU
Medical Practitioners A
12.1.2 Removal of ear wax
D02DC Chlorobutanol + Paradichlorobenzene
Ear Drops 5% + 2% Medical Practitioners A
12.2 Drugs acting on the nose
12.2.1 Drugs used in nasal allergy
R01AD01 Beclometasone Dipropionate Nasal Spray 50mcg Consultants B
12.2.2 Topical nasal decongestants
R01AA03 Ephedrine Nasal Drops 0.5% Medical Practitioners A R01AA07 Xylomethazoline Hydrochloride Nasal Drops 0.05% Medical Practitioners A R01AA07 Xylomethazoline Hydrochloride Nasal Drops 0.1% Medical Practitioners A
12.2.3 Nasal preparations for infection
D08AC52 Neomycin Sulphate + Chlorhexidine Hydrochloride
Nasal Cream 0.5% + 0.1%
Hospital Doctors
V1.3 March 2012
12. Ear, nose and oropharynx 48
12.3 Drugs acting on the oropharynx
12.3.1 Oropharyngeal anti-infective drugs
A01AB04 Amphotericin Lozenges 10mg Medical Practitioners A
12.3.2 Mouthwashes, gargles, and dentifrices
A01AB03 Chlorhexidine Gluconate Mouthwash 0.2% Dentists, Hospital Doctors A A01AB02 Hydrogen Peroxide Mouthwash 6% Medical Practitioners A
12.3.3 Treatment of dry mouth
A01AD11 Artificial Saliva Solution Designate ENT Consultants, Consultant Oncologists, Consultant Palliative Care
V1.3 March 2012
13. Skin 49
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
13. Skin 13.1 Emollient and barrier preparations
13.1.1 Emollients
D02AX Aqueous Cream Cream Medical Practitioners B D02AX Compound Emollient Preparation
(Currently Lipobase®) Cream Consultant Dermatologists
D02AX Emulsifying Ointment BP Ointment Medical Practitioners B D02AC Paraffin White Soft Cream Hospital Doctors
13.1.1.1 Emollient bath additives
D02AX Emollient Bath Additive Solution Consultant Dermatologists B
13.1.2 Barrier preparations
D02AB Barrier Cream without Cetrimide Cream Consultants B
D02AB Zinc + Castor Oil Cream Medical Practitioners A
13.2 Topical corticosteroids D07AC01 Betamethasone Dipropionate
[Potency: potent] Cream 0.05% Consultant Dermatologists C
D07AC01 Betamethasone Valerate [Potency: potent]
Cream 0.1% Medical Practitioners B
D07AC01 Betamethasone Valerate [Potency: moderate]
Ointment 0.025% Consultant Dermatologists
D07AC01 Betamethasone Valerate [Potency: potent]
Ointment 0.1% Medical Practitioners B
D07AC01 Betamethasone Valerate [Potency: potent]
Scalp Application 0.1% in 30mL
Hospital Doctors B
D07CC01 Clioquinol + Betamethasone [Potency: potent]
Ointment 3% + 0.1%
Medical Practitioners A
D07AD01 Clobetasol Propionate [Potency: very potent]
Cream 0.05% Consultant Dermatologists B
V1.3 March 2012
13. Skin 50
D07AD01 Clobetasol Propionate [Potency: very potent]
Ointment 0.05% Consultant Dermatologists B
D07AD01 Clobetasol Propionate [Potency: very potent]
Scalp Application 0.05%
Consultant Dermatologists B
D07CA01 Fusidic Acid + Hydrocortisone [Potency: mild]
Cream 2% + 1% Medical Practitioners A
D07AA02 Hydrocortisone [Potency: mild] Cream 1% Medical Practitioners A D07AA02 Hydrocortisone [Potency: mild] Ointment 1% Medical Practitioners A D07AB02 Hydrocortisone Butyrate [Potency:
potent] Cream 0.1% Medical Practitioners B
D07AB02 Hydrocortisone Butyrate [Potency: potent]
Cream Fatty Base Medical Practitioners B
D01AC52/ D07XA01
Miconazole + Hydrocortisone [Potency: mild]
Cream 2% + 1% Consultant Dermatologists
D07AC13 Mometasone Furoate [Potency: potent]
Cream 0.1% Consultant Dermatologists
D07AC13 Mometasone Furoate [Potency: potent]
Ointment 0.1% Consultant Dermatologists
D07XC01 Salicylic Acid + Betamethasone [Potency: potent]
Ointment 3% + 0.05%
Consultant Dermatologists C
D07XC01 Salicylic Acid + Betamethasone [Potency: potent]
Scalp Application 2% + 0.05%
Consultant Dermatologists
D07XA01 Urea + Lactic Acid + Hydrocortisone [Potency: mild]
Cream 10% + 5% + 1%
Consultant Dermatologists
13.3 Preparations for eczema and psoriasis
13.3.1 Preparations for psoriasis
D05BB02 Acitretin Capsules 10mg Consultant Dermatologists D05BB02 Acitretin Capsules 25mg Consultant Dermatologists D05AX02 Calcipotriol Cream 50mcg/g Consultant Dermatologists D05AX02 Calcipotriol Ointment 50mcg/g Consultant Dermatologists D05AX52 Calcipotriol + Betamethasone
[Potency: potent] Ointment 50mcg + 0.05%/g
Consultant Dermatologists
D05AA Coal Tar Shampoo Medical Practitioners B EXTEMP Miconazole + Hydrocortisone
Butyrate Cream Consultant Dermatologists
EXTEMP Salicylic Acid + Betamethasone Cream Consultant Dermatologists
V1.3 March 2012
13. Skin 51
EXTEMP Salicylic Acid + Betamethasone Ointment Consultant Dermatologists EXTEMP Salicylic Acid + Clobetasol Cream Consultant Dermatologists EXTEMP Salicylic Acid + Clobetasol Ointment Consultant Dermatologists EXTEMP Menthol + Aqueous Cream Cream Consultant Dermatologists
13.3.2 Drugs affecting the immune response
L04AD01 Ciclosporin (Cyclosporin) Capsules 25mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Capsules 100mg Consultants MP 46 L04AD01 Ciclosporin (Cyclosporin) Oral Solution
100mg/mL Consultant Nephrologists, Consultant Dermatologists, Consultant Rheumatologists, Consultant Paediatricians, Consultant Haematologists, Consultant Cardiac Surgeons
MP 47
L01BA01 Methotrexate Tablets 2.5mg Consultants
13.4 Acne
13.4.1 Topical preparations for acne
D10AE01 Benzoyl Peroxide Cream 5% Consultant Dermatologists C D10AE01 Benzoyl Peroxide Gel 2.5% Consultant Dermatologists C D10AE01 Benzoyl Peroxide Gel 5% Consultant Dermatologists C
13.4.2 Oral preparations for acne
D10BA01 Isotretinoin Capsules 20mg Consultant Dermatologists C
13.5 Other preparations 13.5.1 Topical Retinoids
D10AD01 Tretinoin Cream 0.05% Consultant Dermatologists
13.6 Anti-infective skin preparations
13.6.1 Antibacterial preparations
13.7.1.2 Antibacterial preparations also used systemically
D06AX01 Fusidate Sodium Ointment 2% Medical Practitioners A D06AX01 Fusidic Acid Cream 2% Medical Practitioners A D06AX07 Gentamicin Ointment 0.1% Hospital Doctors A D06BX01 Metronidazole Gel 0.8% Consultant Oncologists, Consultant Palliative Care, Consultant
Dermatologists MP 129
13.6.2 Antifungal preparations
D01AC01 Clotrimazole Cream 1% Medical Practitioners A D01AC02 Miconazole Cream 2% Medical Practitioners A D01AA01 Nystatin Cream 100000 IU Medical Practitioners A
V1.3 March 2012
13. Skin 52
13.6.3 Antiviral preparations
D06BB03 Aciclovir (Acyclovir) Cream 5% Consultant Dermatologists A
13.6.4 Parasiticidal preparations
P03AX03 Malathion Liquid 0.5% w/w Medical Practitioners A P03AC04 Permethrin Shampoo with rinse
base 1% Medical Practitioners A
P02CF01 Ivermectin Tablets 3mg Consultants, Senior Public Health Physicians A
13.6.5 Preparations for minor cuts and abrasions
D11AX05 Magnesium Sulphate Paste Medical Practitioners A
13.7 Skin cleansers and antiseptics
13.7.1 Chlorhexidine salts
D08AC02 Chlorhexidine Gluconate in Isopropyl Alcohol
Solution (Hand Cleansing)
Infection Control Policy TBDF MDHP only (TPN patients only) MP 37
13.7.2 Iodine
D08AG03 Iodine Weak Solution Solution Hospital Doctors
13.7.3 Oxidisers and dyes
D08AX01 Hydrogen Peroxide Solution 6% Medical Practitioners A
13.7.4 Preparations for promotion of wound healing
Trolamine (Biafine®) Emulsion Consultant Dermatologists, Consultant Oncologists, Consultant Surgeons
MP 201
13.8 Sunscreen preparations Sunscreen SPF 50+ Milk or Lotion Consultant Dermatologists, Consultant Rheumatologists MP 180
V1.3 March 2012
14. Anaesthesia 53
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
14. Anaesthesia 14.1 General anaesthesia 14.1.1 Antimuscarinic Drugs
A03AB03 Glycopyrolate (Glycopyrronium) (stand-by)
Injections 0.6mg Hospital Doctors as specified by department TBDF MDHP only
A04AD01, N05CM05
Hyoscine Hydrobromide Injections 400mcg Consultant Palliative Care HDO
14.1 Local anaesthesia D04AB01 Lidocaine Hydrochloride
(Lignocaine Hydrochloride) Gel 2% Hospital Doctors C
(Catheteri-sation)
14.2 Topical local anaesthetics and antipruritics D04AX Calamine Lotion Cream/Lotion Medical Practitioners A D04AX Crotamiton Cream Medical Practitioners A
V1.3 March 2012
15. Consumables 54
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
15. Consumables STOMA Stoma and Related Consumables Consultants
Consumables Consultants
V1.3 March 2012
Appendix 1: Borderline substances 55
ATC Code Active Ingredient Dosage Form and
Strength
Prescriber Criteria Protocol Pink
Card
A1 Borderline substances A1.1 Enteral feeds (non-disease specific)
A1.1.1 Enteral feeds (non-disease specific): less than 5g protein/100mL
A1.1.1.1 Enteral feeds: 1kcal/mL and less than 5g protein/100mL
V06 Complete Nutritional Preparation (Nutrison® or Nutricomp® Standard)
Liquid 500mL Medical Practitioners C
A1.1.2 Enteral feeds (non-disease specific): 5g (or more) protein/100mL
A1.1.2.1 Enteral feeds: 1.5kcal/mL and 5g (or more) protein/100mL
V06 Complete Nutritional Preparation (Resource Energy®, formerly known as Ensure® or Clinutren®)
Liquid 200mL Medical Practitioners C
A1.1.2.2 Enteral feeds: less than 1kcal/mL and less than 5g protein/100mL
V06 Elemental Formulas (Elemental 028® Extra)
Powder Consultant Paediatricians, Consultant Gastroenterologists MP 61
A1.1.3 Enteral feeds (non-disease specific): Child under 12 years
A1.1.3.1 Enteral feeds, Child: 1kcal/mL and less than 4g protein/100mL
V06 Paediatric whole protein tube feed (Paediasure®)
Liquid Consultant Paediatricians MP 158
A1.2 Nutritional supplements (non-disease specific)
A1.2.1 Nutritional supplements: 5g (or more) protein/100mL
A1.2.2.2 Nutritional supplements: More than 1.5kcal/mL and 5g (or more) protein/100mL V06 Diet Supplementation (FoodLink®,
Sustagen®) Powder Hospital Doctors C
V1.3 March 2012
Appendix 1: Borderline substances 56
A1.3 Specialised formulas
A1.3.1 Specialised formulas: Infant and child – Amino acid-based formula
V06 Elemental Infant Formula (Neocate®)
Powder Consultant Paediatricians MP 62
A1.3.2 Specialised formulas: Infant and child – Hydrolysate formula V06DF Milk Substitute (Pregestimil®) Powder Hospital Doctors
A1.3.3 Specialised formulas: Infant and child – Soya-based formula
V06DF Milk Substitute [Soya Based] (SMA ® Wysoy)
Powder Hospital Doctors
A1.4 Feed supplements
A1.4.1 High-energy supplements
A1.4.1.1 High-energy supplements: carbohydrate
V06 Carbohydrate Source Supplement (Maxijul®)
Powder Consultants MP 32
V06 Low Electrolyte Syrup (Maxijul®) Solution Hospital Doctors C
A1.4.1.2 High-energy supplements: fat
V06 Fat and Carbohydrate Food Supplement (Duocal®)
Powder Consultant Paediatricians MP 68
A1.4.1.3 High-energy supplements: protein
V06B Protein (Forceval®) Powder Hospital Doctors V06B Protein (Casilan®, Promod®,
Protifar®) Powder 70-90% (high)
Hospital Doctors
A1.5 Feed additives
A1.5.1 Feed thickeners and pre-thickened food
Fluid thickener Powder Consultants C
A1.5.2 Flavouring preparations
Flavour Sachets (to be added with SHS products)
Sachets Consultant Paediatricians, Consultant Gastroenterologists, Dieticians
MP 232
A1.6 Foods for special diets
A1.6.1 Gluten-free foods Gluten-free baking powder Powder Consultant Gastroenterologists, Consultant Paediatric
Gastroenterologists
V1.3 March 2012
Appendix 1: Borderline substances 57
Gluten-free bread 250g Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free cracker bread Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free fibre biscuits Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free flavoured biscuits Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free flour Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free pasta 500g Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
Gluten-free plain biscuits Consultant Gastroenterologists, Consultant Paediatric Gastroenterologists
A1.6.2 Low-protein foods Low-protein bread Consultants Low-protein cracker bread Consultants Low-protein flavoured biscuits Consultants Low-protein flour Consultants Low-protein pasta Consultants Low-protein plain biscuits 200g Consultants
V1.3 March 2012
Index 58
Index
A Abacavir, 26 Abacavir + Lamivudine, 26 Acetazolamide, 19, 45 Acetylcysteine, 46 Aciclovir (Acyclovir), 27, 28, 45, 52 Acipimox, 10 Acitretin, 50 Albendazole, 29 Alfacalcidol (1-α Hydroxyvitamin D3), 41 Alimemazine (Trimeprazine Tartrate), 12 Allopurinol, 44 Alpha Tocopheryl (Vitamin E), 41, 42 Amantadine, 21 Amiloride + Furosemide (Frusemide), 5 Amiloride + Hydrochlorothiazide, 5 Amiloride Hydrochloride, 5 Amiodarone HCl, 6 Amitriptyline, 16, 18, 19 Amlodipine, 8 Amoxicillin, 23 Amoxicillin + Clavulanic Acid, 23 Amphotericin, 48 Anostrazole, 37 Antacid Compound Preparation, 1 Anti-Heamophilic Factor IX, 9 Anti-Heamophilic Factor VIII Intermediate (Factor VIII
inhibitor bypassing activity), 9 Aprepitant, 17 Aqueous Cream, 49 Artificial Saliva, 48 Ascorbic Acid, 41 Aspirin, 9, 18 Atenolol, 6 Atorvastatin, 10 Atropine Sulphate, 1, 45 Azathioprine, 3, 36, 43
B Baclofen, 44 Barrier Cream without Cetrimide, 49 Beclometasone Dipropionate, 11, 47 Bendroflumethiazide (Bendrofluazide), 5 Benzatropine Mesylate, 21 Benzoin Tincture, 13 Benzoyl Peroxide, 51 Benzylpenicillin, 23 Beta-Blocker preservative free, 46 Betamethasone Dipropionate, 49 Betamethasone Sodium Phosphate, 45 Betamethasone Valerate, 49 Betaxolol, 46 Betaxolol Hydrochloride, 45 Bexarotene, 35 Bezafibrate, 10 Bicalutamide, 37 Bisacodyl, 3 Bismuth Chelate, 1 Brimonidine Tartrate, 46 Bromazepam, 14 Bromhexine, 13 Bromocriptine Mesylate, 21, 33 Budesonide, 2, 12 Bumetanide, 5 Buspirone Hydrochloride, 14 Busulfan, 35
C Cabergoline, 33 Calamine Lotion, 53 Calciferol, 41 Calcipotriol, 50 Calcipotriol + Betametasone, 50 Calcitonin (Salmon Synthetic), 33 Calcium, 8, 40 Calcium Carbonate, 1, 40
Calcium Folinate (Leucovorin/Folinic Acid), 35 Calcium Lactate, 40 Calcium Polystyrene Sulphonate (Calcium Resonium),
40 Calcium Resonium, 40 Captopril, 7 Carbamazepine, 19 Carbimazole, 31 Carbohydrate Source Supplement (Maxijul®), 56 Carbonic Anhydrase Inhibitors (Currently
Dorzolamide), 46 Carvedilol, 6 Casilan®, 56 Cefalexin, 23 Cefuroxime Axetil, 23 Chlorambucil, 35 Chloramphenicol, 24, 45 Chlorhexidine Gluconate, 48 Chlorhexidine Gluconate in Isopropyl Alcohol, 52 Chlorobutanol + Paradichlorobenze, 47 Chloroquine, 28 Chlorpromazine Hydrochloride, 14 Chorionic Gonadotropin (HCG), 32 Ciclosporin (Cyclosporin), 3, 36, 43, 44, 51 Ciprofloxacin, 26 Clarithromycin, 24 Clindamycin, 24 Clinutren®, 55 Clioquinol + Betamethasone, 49 Clobazam, 19 Clobetasol Propionate, 49, 50 Clodronate, 33 Clofazimine, 25 Clomifene Citrate, 32 Clomipramine Hydrochloride, 16 Clonazepam, 19 Clonidine Hydrochloride, 6, 19 Clopidogrel, 9 Clotrimazole, 34, 51 Clozapine, 15 Coal Tar, 50
V1.3 March 2012
Index 59
Co-amilofruse, 5 Co-Danthramer, 3 Codeine Phosphate, 2, 13, 18 Colchicine, 44 Colestipol, 10 Colestyramine, 3, 10 Colistimethate Sodium (Colistin Sulphomethate
Sodium), 24 Complete Nutritional Preparation (Nutrison® or
Nutricomp®), 55 Complete Nutritional Preparation (Resource Energy®,
formerly known as Ensure® or Clinutren®), 55 Compound Emollient Preparation (Currently
Lipobase®), 49 Conjugated Oestrogens, 32 Conjugated Oestrogens (Equine), 32 Cortisone Acetate, 31 Co-Trimoxazole, 24 Cow & Gate Pepti-Junior®, 56 Cox-2 Selective Inhibitor, 43 Crotamiton, 53 Cyclizine, 17, 19 Cyclopentolate Hydrochloride, 45 Cyclophosphamide, 35 Cycloserine, 24 Cyproheptadine Hydrochloride, 12 Cyproterone Acetate, 37
D Dantrolene Sodium, 44 Dapsone, 25 Deferasirox, 39 Demeclocycline Hydrochloride, 32 Desmopressin, 32, 33 Dexamethasone, 31, 45 Dexamethasone + Framycetin + Gramicidin, 47 Dexamphetamine Sulphate, 17 Diazepam, 14, 21, 44 Diclofenac Sodium, 43 Didanosine, 26, 27 Diet Supplementation (FoodLink®, Sustagen ®), 55 Diethylstilbestrol (Stilboestrol), 37 Digoxin, 5 Dihydrocodeine Tartrate, 18 Diltiazem, 8
Dimenhydrinate, 17 Diphenhydramine Citrate + Menthol, 13 Dipyridamole, 9 Disodium Etidronate, 33 Disopyramide, 6 Distigmine Bromide, 34, 44 Disulfiram, 22 Domperidone, 17 Dorzolamide, 46 Doxazosin, 6, 34 Doxycycline, 23 Duocal®, 56 Dydrogesterone, 32
E Econazole, 34 Efavirenz, 27 Elemental 028® Extra, 55 Elemental Formulas (Elemental 028® Extra), 55 Elemental Infant Formula (Neocate®), 56 Emollient Bath Additive, 49 Emulsifying Ointment BP, 49 Enalapril, 7 Enoxaparin Sodium, 8, 9 Ensure®, 55 Ephedrine, 47 Eptacog Alfa (Recombinant Factor VIIa), 9 Ergotamine Compound, 19 Erlotinib, 35 Erythromycin, 24 Estradiol Valerate, 32 Estradiol Valerate + Norgestrel, 32 Etanercept, 44 Ethambutol, 25 Ethinylestradiol, 32, 37 Ethionamide, 25 Ethosuximide, 19 Etoposide, 35
F Factor XIII Concentrate, 9 Fat and Carbohydrate Food Supplement (Duocal®),
56
Fenofibrate, 10 Ferrous Gluconate, 39 Ferrous Sulphate, 39 Fibrinogen Concentrate, 9 Filgrastim (Rec. Human G-CSF), 40 Finasteride, 32 Flavour Sachets, 56 Flavoxate, 34 Flecainide, 6 Flucloxacillin, 23 Fluconazole, 26 Fludarabine, 35 Fludrocortisone Acetate, 31 Fluid thickener, 56 Flumethasone + Clioquinol, 47 Fluorouracil, 35 Fluoxetine, 17 Flupentixol Decanoate, 16 Flupentixol Dihydrochloride, 15, 17 Fluphenazine Decanoate, 16 Flutamide, 37 Fluticasone, 12 Fluvastatin, 10 Fluvoxamine Maleate, 17 Folic Acid, 39 FoodLink®, 55 Forceval®, 56 Framycetin + Dexamethasone + Gramicidin, 45 Furosemide, 5 Fusidate Sodium, 24, 51 Fusidic Acid, 24, 51 Fusidic Acid + Hydrocortisone, 50
G Gabapentin, 19 Gentamicin, 24, 47, 51 Glibenclamide, 30 Gliclazide, 30 Glucagon, 30 Gluten-free products, 56 Glycerol, 3 Glyceryl Trinitrate, 7 Glycopyrolate (Glycopyrronium), 53 Goserelin, 33 Griseofulvin, 26
V1.3 March 2012
Index 60
Growth Hormone Recombinant, 32
H Haloperidol, 15, 16, 22 Haloperidol Decanoate, 16 Heparin Calcium, 8 Heparin Sodium in Sodium Chloride, 8 Hydralazine, 6 Hydrocortisone, 2, 31, 45, 47, 50 Hydrocortisone + Gentamicin, 47 Hydrocortisone + Polymyxin B + Neomycin, 47 Hydrocortisone Acetate, 45 Hydrocortisone Butyrate, 50 Hydrocortisone Sodium Succinate, 31 Hydrogen Peroxide, 48, 52 Hydroxycarbamide (Hydroxyurea), 36 Hydroxychloroquine Sulphate, 44 Hydroxycobalamin (Vitamin B12), 39 Hydroxyzine Hydrochloride, 12 Hyoscine Butylbromide, 1 Hyoscine Hydrobromide, 53 Hypromellose, 46
I Ibuprofen, 43 Imatinib, 36 Imipramine Hydrochloride, 16 Indinavir, 27 Indometacin, 43 Insulin Aspart, 30 Insulin Biphasic Isophane, 30 Insulin Glargine, 30 Insulin Isophane, 30 Insulin Neutral (Soluble Insulin), 30 Interferon Alfa 2b, 36 Interferon Beta 1a, 37 Interferon Beta 1b, 37 Interferon Gamma, 37 Iodine Weak Solution, 52 Ipratropium, 11 Iron + folic acid, 39 Isoniazid, 25 Isoniazid + Rifampicin, 25
Isosorbide Dinitrate, 7 Isosorbide Mononitrate, 7, 8 Isotretinoin, 51 Ispaghula Husk, 3 Itraconazole, 26 Ivermectin, 29, 52
K Ketoconazole, 26
L Labetalol Hydrochloride, 6 Lactulose, 3 Lamivudine, 26, 27 Lamivudine + Abacavir, 26 Lamotrigine, 19, 20 Lanthanum, 41 Latanoprost, 46 Leflunomide, 44 Lenalidomide, 37 Letrozole, 37 Leuprorelin, 33 Levetiracetam, 20 Levodopa, 21 Levodopa + Benserazide Hydrochloride, 21 Levodopa + Carbidopa, 21 Levodopa + Carbidopa + Entacapone, 21 Levomepromazine, 15 Levothyroxine (Thyroxine), 31 Lidocaine Hydrochloride (Lignocaine Hydrochloride),
53 Liothyronine Sodium (L-Tri-iodothyronine), 31 Lipobase®, 49 Lisinopril, 7 Lisuride Maleate (Lysuride), 33 Lithium Carbonate, 16 Lithium Citrate, 16 Lomustine, 35 Long Acting Beta2-Agonist for patients over 12 years
inhaler, 11 Loperamide, 2 Lopinavir/Ritonavir, 27 Lorazepam, 14
Losartan Potassium, 7 Low Electrolyte Syrup (Maxijul®), 56 Low-protein products, 57
M Magnesium Glycerophosphate, 41 Magnesium Hydroxide + Aluminium Hydroxide +
Simeticone, 1 Magnesium Hydroxide Mixture, 1, 3 Magnesium Sulphate, 52 Malathion, 52 Maprotiline Hydrochloride, 16 Maxijul®, 56 Mebendazole, 28, 29 Mebeverine Hydrochloride, 1 Medical Oxygen, 12 Medroxyprogesterone Acetate, 32, 37 Mefenamic Acid, 43 Mefloquine, 28 Meloxicam, 43 Melphalan, 35 Menadiol Sodium Phosphate, 42 Menthol + Aqueous Cream, 51 Mepacrine Hydrochloride, 28 Mercaptopurine, 3, 35 Mesalazine, 2 Metformin, 30 Methadone HCl, 18 Methotrexate, 3, 35, 44, 51 Methylcellulose, 3 Methyldopa, 6 Methylphenidate Hydrochloride, 17 Methylprednisolone, 31, 43 Methylprednisolone Acetate, 31, 43 Methylprednisolone Sodium Succinate, 31 Metoclopramide, 17 Metolazone Tartrate, 5 Metoprolol Tartrate, 6 Metronidazole, 26, 51 Mexiletine HCl, 6 Mianserin Hydrochloride, 16 Miconazole, 51 Miconazole + Hydrocortisone, 50 Miconazole + Hydrocortisone Butyrate, 50
V1.3 March 2012
Index 61
Milk Substitute (Pregestimil®, Cow & Gate Pepti-Junior®), 56
Milk Substitute [Soya Based] (SMA® Wysoy), 56 Minoxidil, 6 Misoprostol, 2 Moclobemide, 17 Mometasone Furoate, 50 Montelukast, 12 Morphine Sulphate, 18 Moxifloxacin, 26 Multivitamins, 42 Multivitamins (Abidec), 42 Multivitamins (Cernevit™-12), 42 Multivitamins + mineral preparation (ketovite), 42 Mycophenolate Mofetil, 36 Mycophenolate Sodium, 36
N Naltrexone Hydrochloride, 22 Naproxen, 43 Neocate®, 56 Neomycin, 47 Neomycin Sulphate + Chlorhexidine Hydrochloride, 47 Nevirapine, 27 Niclosamide, 29 Nicorandil, 8 Nicotinamide, 41 Nifedipine, 8 Nimodipine, 8 Nitazoxanide, 28 Nitrazepam, 14 Nitrofurantoin, 26 Norethisterone, 32 Norfloxacin, 26 Nortriptyline, 16, 19 Nutricomp®, 55 Nutrison®, 55 Nystatin, 26, 34, 51
O Octreotide, 37 Octreotide Long Acting, 37, 38 Olanzapine, 15
Omalizumab, 12 Omeprazole, 2 Ondansetron, 17 Oral Rehydration, 40 Orphenadrine Hydrochloride, 21 Oxybutynin Hydrochloride, 34
P Paediasure®, 55 Paediatric whole protein tube feed (Paediasure®), 55 Pancreatin, 4 Paracetamol, 18 Paradichlorobenzene, 47 Paraffin White Soft, 49 Paroxetine, 17 Penicillamine, 44 Pentasa, 2 Pentazocine, 18 Pentoxifylline (Oxypentifylline), 8 Perindopril, 7 Permethrin, 52 Pethidine Hydrochloride, 18 Phenindione, 9 Phenobarbital (Phenobarbitone), 20 Phenoxybenzamine, 7 Phenoxymethylpenicillin (penicillin V), 23 Phenytoin Sodium, 20 Phosphate Enema, 3 Phosphate Supplement, 41 Phytomenadione (Vitamin K1), 42 Pilocarpine Hydrochloride, 46 Pimozide, 15 Piroxicam, 43 Polymyxin B, 47 Potassium Chloride, 40 Potassium Citrate + Citric Acid, 34 Potassium Supplement, 40 Praziquantel, 29 Prazosin, 7, 34 Prazosin Hydrochloride, 7 Prednisolone, 2, 11, 31, 45 Prednisolone Sodium Phosphate, 45 Prednisone Acetate, 11 Pregabalin, 19, 20 Pregestimil®, 56
Primidone, 20 Procarbazine, 36 Prochlorperazine, 15, 17 Procyclidine, 21, 22 Proguanil Hydrochloride, 28 Proguanil Hydrochloride + Atovaquone, 28 Promethazine Hydrochloride, 12, 14 Promod®, 56 Propafenone, 6 Propantheline Bromide, 1 Propranolol Hydrochloride, 6 Propylthiouracil, 31 Prostaglandin Analogues ( Latanoprost ), 46 Prostaglandin Analogues Preservative-free
(Travoprost), 46 Protein (Casilan®, Promod®, Protifar®), 56 Protein (Forceval®), 56 Protifar®, 56 Protionamide, 25 Pyrazinamide, 25 Pyridostigmine Bromide, 44 Pyridoxine (Vitamin B6), 41 Pyrimethamine, 28 Pyrimethamine + Sulphadoxine, 28
Q Quetiapine, 15 Quinidine Bisulphate, 6
R Ranitidine, 1 Rasagiline, 21 Rec. Human G-CSF, 40 Recombinant Factor VIIa, 9 Recombinant Human Erythropoietin, 39 Resource Energy®, 55 Rifabutin, 25 Rifampicin, 25 Risperidone, 15, 16 Ritonavir, 27 Ropinirole, 21 Rufinamide, 20
V1.3 March 2012
Index 62
S Salbutamol, 11 Salicylic Acid + Betamethasone, 50, 51 Salicylic Acid + Clobetasol, 51 Salmeterol, 11 Saquinavir, 27 Selegiline, 21 Senna, 3 Simvastatin, 10 Sirolimus, 36 SMA® Wysoy, 56 Sodium Bicarbonate, 40 Sodium Cromoglicate, 45 Sodium Feredetate, 39 Sodium Valproate, 20 Sotalol, 6 Spironolactone, 5 Stavudine, 27 Stilboestrol, 37 Sucralfate, 1 Sulfadiazine, 24 Sulfasalazine, 2, 44 Sulfinpyrazone, 44 Sulpiride, 15 Sunitinib, 36 Sunscreen SPF 50+, 52 Sustagen®, 55
T Tacrolimus, 36 Tamoxifen, 32, 37 Temazepam, 14 Temozolomide, 36 Tenofovir, 27 Terbutaline, 11 Teriparatide, 33 Testosterone Enantate Depot, 32 Testosterone Undecanoate, 32 Tetrabenazine, 22 Tetracycline, 23 Thalidomide, 25, 37 Theophylline, 11 Thiamine (Vitamin B1), 41 Timolol, 46
Timolol Maleate, 46 Tioguanine, 35 Topiramate, 20 Tramadol, 18 Tranexamic Acid, 9 Travoprost, 46 Tretinoin, 36, 51 Trifluoperazine, 15 Trihexyphenidyl Hydrochloride (Benzhexol
Hydrochloride), 22 Trimetazidine Hydrochloride, 8 Trimethoprim, 24 Trimipramine, 16 Trolamine, 52 Tropicamide, 45
U Urea + Lactic Acid + Hydrocortisone, 50 Ursodeoxycholic Acid, 3
V Valganciclovir, 28 Valsartan, 7 Vancomycin, 24 Venlafaxine, 17 Verapamil, 8 Vigabatrin, 20 Vitamin A (Retinol), 41 Vitamin A + D, 41 Vitamin B Complex (Nicotinamide + Riboflavin +
Thiamine), 41
W Warfarin, 9 Water for injection, 40
X Xylomethazoline Hydrochloride, 47
Z Zidovudine (Azidothymidine), 27 Zidovudine + Lamivudine, 27 Zinc + Castor Oil, 49 Zoledronic Acid, 33 Zuclopenthixol Acetate, 15 Zuclopenthixol Decanoate, 16 Zuclopenthixol Dihydrochloride, 15, 16